Microenvironment viscosity sensitive fluorescent dye, preparation method therefor, and use thereof
By developing a microenvironment viscosity-sensitive fluorescent dye, the problems of high background fluorescence and short lifetime of existing fluorescent dyes in living cells have been solved, achieving low background fluorescence, long wavelength emission and good photostability, which is suitable for long-term dynamic tracking of biological substances and in vivo imaging.
Patent Information
- Application Number
- PCT/CN2024/091649
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-09
- Filing Date
- 2024-05-08
- Publication Date
- 2024-11-14
AI Technical Summary
Existing fluorescent dyes exhibit high background fluorescence in living cells and poor tissue penetration, making it difficult to achieve long-term dynamic tracking and in vivo imaging. Furthermore, their short fluorescence lifetime makes it difficult to accurately detect biomolecular structures and interactions.
To develop a microenvironment viscosity-sensitive fluorescent dye with a structure containing specific functional groups, whose fluorescence intensity varies with solution viscosity, exhibiting long-wavelength emission, good photostability, and long fluorescence lifetime, suitable for long-term monitoring and precise imaging of biological substances.
It achieves low background fluorescence, long wavelength emission, good photostability and long fluorescence lifetime, making it suitable for long-term dynamic tracking and in vivo imaging at the cellular level, and enabling precise detection of biomolecular structures and interactions.
Smart Images

Figure PCTCN2024091649-FTAPPB-I100001 
Figure PCTCN2024091649-FTAPPB-I100002 
Figure PCTCN2024091649-FTAPPB-I100003
Abstract
Description
A microenvironment viscosity-sensitive fluorescent dye and its preparation method and use Technical field:
[0001] The invention relates to a fluorescent dye sensitive to microenvironment viscosity and a preparation method and application thereof. Background technology:
[0002] Fluorescence imaging techniques have become indispensable tools in biomedical research, and the development of fluorescent dyes has become a crucial component of chemical biology. Among these, the development of small-molecule fluorescent dyes is particularly important due to their small size, rapid cell membrane penetration, high sensitivity, and fast response time, offering advantages over fluorescent protein-based probes in optical imaging and analytical sensing. Currently, fluorescent dyes are widely used for cell staining, construction of environmental sensors, and fluorescent labeling of biomolecules. Consequently, a large number of fluorescent dyes have been developed over the past few decades. Most of these fluorescent dyes are based on classic dye "cores" such as coumarin, fluorescein, BODIPY, or cyanine (LD Lavis, ACS Chem. Biol. 2008, 3, 3, 142–155; LD Lavis, ACS Chem. Biol. 2014, 9, 855–866). However, most of these fluorescent dyes are always-on fluorescent, resulting in high background fluorescence when used for fluorescence imaging in living cells. In addition, most fluorescent dyes developed based on these classic parent nuclei have short wavelengths and poor tissue penetration. Among them, although cyanine dyes have longer wavelengths, they have poor biological stability and are therefore difficult to apply to in vivo fluorescence imaging.
[0003] In response to the problem of high background fluorescence of current fluorescent dyes, activated fluorescent dyes have emerged (H. Tian, Chem. Soc. Rev., 2019, 48, 683-722. W. Huang, Chem. Soc. Rev., 2022, DOI: 10.1039 / d2cs00562j.). In principle, they do not fluoresce or fluoresce weakly before binding to the target substance, and the fluorescence lights up or is significantly enhanced after binding to the target substance. Currently, there are two main types of activated fluorescent dyes that are widely used: quenching group-modified always-on fluorescent dyes and environmentally sensitive fluorescent dyes. Quenching group-modified always-on fluorescent dyes refer to compounds formed by covalently binding always-on fluorescent dyes such as coumarin, fluorescein and rhodamine to a quenching group through a connecting chain (A. Jaschke, Angew. Chem. Int. Ed. Engl., 2013, 52, 13401-13404.). The dye molecule and the quencher group undergo a FRET or PET effect, quenching the dye's fluorescence. When this compound binds to the target molecule, the energy transfer effect is disrupted, and fluorescence is restored. Environmentally sensitive fluorescent dyes are fluorescent dyes whose fluorescence changes depending on the microenvironment in which the dye molecule resides. They are categorized as solvation-sensitive and viscosity-sensitive (M. Ryckelynck, Int. J. Mol. Sci., 2017, 19). Environmentally sensitive dyes have attracted considerable attention due to their smaller molecular structure, lower background fluorescence, and higher sensitivity compared to quencher-modified, always-on fluorescent dyes.
[0004] Although various environmentally sensitive fluorescent dyes have been developed, such as CCVJ, HBI and thioflavin T (B.Shen, J Mater Chem B, 2020, 8, 9642-9651; G.-i.Konishi, Journal of Materials Chemistry C, 2016, 4, 2731-2743.), their emission wavelengths are short and their photostability is poor, making them difficult to apply to long-term dynamic tracking at the cellular level, and even more difficult to achieve in vivo fluorescence imaging. Therefore, it is crucial to develop environmentally sensitive fluorescent dyes with long emission wavelengths, good photostability and low background fluorescence. At present, there have been some breakthroughs in the development of long-wavelength environmentally sensitive fluorescent dyes, with the longest emission wavelength reaching 700nm (Z.Nie, J.Am.Chem.Soc., 2021, DOI: 10.1021 / jacs.1c04577.), but the excitation wavelengths of these fluorescent dyes are short, making it difficult to achieve red light excitation and red light emission. This means that although these molecules can achieve long-wavelength emission, they still cannot avoid the interference of in vivo autofluorescence (background fluorescence) caused by short-wavelength excitation. In addition, these dyes have poor photostability and low fluorescence quantum yield, making them unsuitable for long-term tracking and in vivo imaging of biological substances. Therefore, the development of environmentally sensitive fluorescent dyes with long excitation and emission wavelengths, good photostability, and high fluorescence quantum yield is of great significance.
[0005] Furthermore, the fluorescence lifetime of a fluorescent dye is a more accurate indicator of biomolecular structure or interactions, as it is dependent solely on its structure and the microenvironment in which it resides (e.g., polarity, viscosity, and other conditions), and is unrelated to laser intensity or the presence of photoquenching (K. Suhling, J. Am. Chem. Soc. 2008, 130, 21, 6672–6673). In principle, the fluorescence lifetime of an environmentally sensitive dye can directly reflect the microenvironment in which the dye resides. However, the fluorescence lifetimes of currently developed environmentally sensitive fluorescent dyes are generally short, reaching only about 1 nanosecond in the microenvironment with the longest fluorescence lifetime. Such short fluorescence lifetimes make accurate detection difficult with conventional instruments. Therefore, the development of environmentally sensitive fluorescent dyes with longer fluorescence lifetimes would provide essential tools for precise in vitro and in vivo imaging and detection of biological substances.
[0006] Summary of the invention:
[0007] The fluorescent dye molecules of the present invention do not fluoresce in a free state, but can activate fluorescence under microenvironments with higher viscosities such as glycerol. This is a brand-new microenvironment viscosity-sensitive fluorescent dye, and this type of dye has obvious viscosity responsiveness, and its fluorescence intensity changes with the viscosity of the microenvironment, and the higher the viscosity, the stronger the fluorescence intensity. In addition, this type of dye molecules has a longer emission wavelength and fluorescence brightness, and can maintain good light stability under the excitation conditions of high laser intensity, and is not prone to photobleaching, meeting the needs of long-term monitoring of biological substances in vivo and in vitro detection. In addition, this type of dye molecules has a longer fluorescence lifetime, and the fluorescence lifetime changes along with the changes in the microenvironment where the dye resides, and the structure and interaction of biological substances can be studied by monitoring the changes in the fluorescence lifetime.
[0008] Specifically, the present invention provides a fluorescent dye having a structure as shown in formula (I),
[0009] in:
[0010] A is -N(X1)(X2) or HO-, and B is =N + (X3)(X4) or =O, or X1, X2 and R2 and / or R3, or X3, X4 and R4 and / or R5 are linked to form a heterocyclic group;
[0011] X1, X2, X3, and X4 are each independently selected from at least one of hydrogen, alkyl, modified alkyl, aryl, heteroaryl, and unsaturated or saturated heterocyclic groups, or X1 and X2, or X3 and X4 are optionally connected to each other to form a saturated or unsaturated unsubstituted or R 1-1 substituted heterocyclic or heteroaromatic ring, or X1, X2 and R2 and / or R3, or X3, X4 and R4 and / or R5 are optionally connected to each other to form a saturated or unsaturated unsubstituted or R 1-1 substituted heterocyclic groups;
[0012] and / or R1, R2, R3, R4, R5, R6 are optionally independently selected from hydrogen, a halogen atom, a nitro group, or an alkyl group;
[0013] When K is selected from S, Se, Te, Te=O, unsubstituted or 1 or 2 R 1-1 Substituted carbon, unsubstituted or 1 or 2 R 1-1 Substituted germanium, (R0 are each independently selected from ), G is selected from the following formula (I-1-1), formula (I-1-2), formula (I-1-3) or (I-1-4);
[0014] When K is selected from O or unsubstituted or 1 or 2 R 1-1When the silicon is substituted and A is not -N(X1)(X2), G is selected from the following formula (I-1-1), formula (I-1-2), formula (I-1-3) or formula (I-1-4).
[0015] When K is selected from O or unsubstituted or 1 or 2 R 1-1 When A is -N(X1)(X2) and B is =N+(X3)(X4), G is selected from the following formula (I-1-2) or formula (I-1-3);
[0016] in,
[0017] Each R 1-1 are each independently selected from a halogen atom or an alkyl group;
[0018] Each Y is independently selected from O, S, NH, Se, or Te;
[0019] Each Z is independently selected from C, or N,
[0020] Each R a , each R b , each R c Each is independently selected from hydrogen, sulfonic acid group, haloacyl group, cyano group, cyanate group, isothiocyanate group, carboxyl group, ester group, amide group, nitro group, halogen atom, alkyl group, haloalkyl group, modified alkyl group;
[0021] The C ring in formula (I-1-2) and the E ring in formula (I-1-3) are each independently selected from at least one of an aromatic ring or an aromatic heterocycle;
[0022] Each hydrogen atom in formula (I-1-2) and formula (I-1-3) is optionally substituted independently by a halogen atom or an alkyl group;
[0023] D in formula (I-1-2) and F in formula (I-1-3) are each independently selected from hydrogen, cyano, amino, isothiocyanate, carboxyl, sulfone, phosphite, ester, amide, nitro, halogen, alkyl, aryl, heteroaryl, or modified alkyl;
[0024] in,
[0025] The "alkyl" is C1-C 10Straight or branched alkyl; preferably, C1-C7 straight or branched alkyl; preferably, C1-C5 straight or branched alkyl; preferably, selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, isopentyl, 1-ethylpropyl, neopentyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl ... hexyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, 2-ethylbutyl, n-heptyl, 2-methylhexyl, 3-methylhexyl, 2,2-dimethylpentyl, 3,3-dimethylpentyl, 2,3-dimethylpentyl, 2,4-dimethylpentyl, 3-ethylpentyl, or 2,2,3-trimethylbutyl;
[0026] The "modified alkyl" is a group obtained by replacing any carbon atom of an alkyl group with at least one group selected from a halogen atom, -O-, -OH, -CO-, -NO2, -CN, -S-, -SO2-, -(S=O)-, an aryl group optionally substituted with a halogen atom, an amino group, a secondary amino group, a tertiary amino group, a heterocyclic group, a saturated or unsaturated monocyclic or heterocyclic ring, and the modified alkyl group has 1 to 30 carbon atoms (preferably 1 to 20 carbon atoms, more preferably less than 10 carbon atoms), and its carbon-carbon single bond is optionally independently replaced by a carbon-carbon double bond or a carbon-carbon triple bond;
[0027] The carbon atom is replaced, which means that the carbon atom or the carbon atom together with the hydrogen atoms thereon are replaced by the corresponding group;
[0028] The "heterocyclic group" is a 4-10 membered monocyclic or polycyclic heterocyclic group containing at least one heteroatom selected from N, O, S or Si in the ring;
[0029] The "aryl" or "aromatic ring" is a 5-10 membered monocyclic or fused bicyclic aromatic group;
[0030] The "heteroaryl" or "aromatic heterocycle" is a 5-10 membered monocyclic or fused bicyclic heteroaromatic group containing at least one heteroatom selected from N, O, S or Si in the ring;
[0031] The halogen atoms in the "halogen atom", "haloalkyl", "haloacyl" and "halogen-substituted aryl" are each independently selected from F, Cl, Br and I;
[0032] The "ester group" is -(C=O)OR 1-2 group;
[0033] The "amide group" is -CONR 1-2 group;
[0034] The "sulfone group" is -SO2R 1-2 group;
[0035] The "sulfoxide" -SOR 1-2 group;
[0036] The "secondary amino group" is -NHR 1-2 group;
[0037] The "tertiary amino group" is -NR 1-2 R 1-3 group;
[0038] Each R 1-2 、R 1-3 Each is independently H, an alkyl group, a modified alkyl group or a halogen atom.
[0039] Optionally, among the above fluorescent dyes,
[0040] X1, X2 and R2 and / or R3 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formula:
[0041] X3, X4 and R4 and / or R5 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formula:
[0042] Preferably, the heterocyclic group formed by X1, X2 and R2 and / or R3 or X3, X4 and R4 and / or R5 is a symmetrical structure;
[0043] Preferably, each R' is independently selected from hydrogen or alkyl;
[0044] Preferably, X1 and X2 are optionally linked to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formulae, wherein the following groups are optionally substituted by halogen atoms;
[0045] Preferably, X3 and X4 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formulae, wherein the following groups are optionally substituted by halogen atoms;
[0046] Preferably, the heterocyclic group composed of X1 and X2, X3 and X4 is a symmetrical structure;
[0047] Preferably, K is selected from oxygen, sulfur, selenium, tellurium or the following groups:
[0048] Optionally, among the above fluorescent dyes,
[0049] Preferably, formula (I-1-1) and (I-1-4) are selected from any one of the following groups:
[0050] Preferably, formula (I-1-2) can be selected from any one of the following groups:
[0051] Alternatively, formula (I-1-3) may be selected from any of the following groups:
[0052] Optionally, the fluorescent dye represented by formula (I) of the present invention is selected from the following compounds:
[0053] The viscosity-responsiveness of the fluorescent dye mentioned above means that the fluorescence intensity of the dye molecule responds to the viscosity of the solution, and the fluorescence intensity increases as the viscosity of the solution increases. Optionally, the viscosity-responsive fluorescent dye is an organic dye molecule whose maximum fluorescence emission intensity in glycerol and in methanol is greater than 10, preferably greater than 100, and more preferably greater than 1000 at 25°C and under the same concentration and excitation wavelength. The concentration range of the viscosity-responsive dye is 1×10 -7 M-1×10 -5 M.
[0054] The fluorescent dyes are tunable in structure and have long fluorescence emission wavelengths, up to 900 nm. Operators can select dyes of different types or emission / excitation wavelengths as needed.
[0055] The fluorescence intensity of the fluorescent dye increases with the increase of the environmental viscosity, and the fluorescent dye responds sensitively to the viscosity and has viscosity responsiveness.
[0056] The above-mentioned fluorescent dyes have excellent photostability and are not easily photobleached under laser irradiation, and can perform long-term dynamic tracking of target molecules.
[0057] The above fluorescent dyes can be used for specific labeling of target substances such as proteins or nucleic acids. After the fluorescent dyes bind to the target substances, the fluorescence can be activated, and they have good fluorescent molecular switch properties, high fluorescence activation multiples, and high fluorescence activation brightness.
[0058] The above fluorescent dyes can label the analytes very quickly.
[0059] The fluorescence intensity of the fluorescent dye has a good linear relationship with the concentration of the analyte, and can be used for quantitative detection of analytes, including but not limited to proteins, nucleic acids, and metabolic molecules.
[0060] The above fluorescent dyes can specifically label biological substances in cells and achieve specific fluorescence lighting. At the same time, the probe fluorescence is not affected by the intracellular environment.
[0061] The above fluorescent dyes can be used as powerful tools for labeling cellular subcellular organelles, such as the nucleus, mitochondria, Golgi apparatus, endoplasmic reticulum, whole cells, cytoskeleton, extracellular membrane, lysosomes, intracellular membranes, etc.
[0062] The spectra of the fluorescent groups of the above fluorescent dyes will not interfere with each other. The fluorescent dyes of different color systems of the present invention can perform multi-color labeling on samples and can perform orthogonal labeling imaging at the same time.
[0063] The fluorescent dyes mentioned above have a long fluorescence lifetime, and the fluorescence lifetime changes with changes in the microenvironment in which the dyes are located.
[0064] In a second aspect, the present invention provides a method for preparing the fluorescent dye represented by the above-mentioned formula (I), comprising reacting a brominated aromatic ring compound represented by formula (II-1-1), or formula (II-1-2), or formula (II-1-3), or formula (II-1-4) with a ketone represented by (II-2) to obtain a fluorescent dye represented by formula (I):
[0065] A third aspect of the present invention provides a method for specific fluorescent labeling of biological substances, comprising the following steps: contacting a fluorescent dye with a biological substance (including but not limited to protein, RNA, or DNA), wherein the dye and the biological substance undergo covalent or non-covalent binding, thereby specifically activating the fluorescence of the dye molecule and achieving specific fluorescent labeling of the biological substance. Those skilled in the art can use correspondingly configured instruments and equipment to track and monitor the target substance after dye labeling, as needed. The instruments and equipment used include equipment and facilities capable of measuring or displaying fluorescence, such as fluorescence spectrometers, fluorescence microscopes, confocal fluorescence microscopes, microplate readers, flow cytometers, and the like.
[0066] Optionally, the reaction medium of the labeling reaction is selected from a pure analyte solution (pure protein, pure DNA and RNA, etc.), a cell lysate or an in situ medium where the analyte is located; optionally, the in situ medium is an intracellular medium, an intracellular organelle medium, a living tissue medium, blood or body fluid.
[0067] A fourth aspect of the present invention provides a probe kit, characterized in that it comprises the above-mentioned fluorescent dye.
[0068] Optionally, the probe kit further comprises a biocompatible medium; optionally, the biocompatible medium is selected from at least one of dimethyl sulfoxide, a buffer, and physiological saline; optionally, the buffer comprises a phosphate buffer.
[0069] A fifth aspect of the present invention provides a pharmaceutical preparation, characterized in that it comprises the above-mentioned fluorescent dye.
[0070] Alternatively, the pharmaceutical preparation is a pharmaceutical composition prepared by mixing fluorescent dyes with other compounds and suitable for administration to animals or humans. The pharmaceutical composition also includes a physiologically acceptable carrier for animals or humans.
[0071] Alternatively, physiologically acceptable carriers include water, saline, and may also include pharmaceutical agents such as buffers, and other pharmaceutical agents such as compatible preservatives used in pharmaceutical dosage forms.Preferably, the carrier is a liquid, more preferably an aqueous solution.
[0072] The sixth aspect of the present invention also provides the in vitro application of the above-mentioned fluorescent dye, which includes the use of the fluorescent dye in the preparation of pharmaceutical preparations for in vitro disease detection, including but not limited to labeling fluorescent dye molecules on antibodies to detect various diseases through antigen-antibody interactions; or using fluorescent dye molecules as targets for screening nucleic acid aptamers, and using the screened aptamers to perform fluorescent imaging of target nucleic acids and use them as probes for the detection of various disease markers.
[0073] The seventh aspect of the present invention further provides the in vivo application of the above-mentioned fluorescent dye, and the in vivo application includes the use of the above-mentioned fluorescent dye in the preparation of an optical imaging system for in vivo fluorescence imaging detection or treatment; optionally, the in vivo fluorescence imaging detection or treatment includes performing fluorescence-guided surgery or in vitro tissue staining on human bodies or animals through fluorescence imaging or fluorescence lifetime imaging.
[0074] Fluorescence imaging performed in animal experiments includes, but is not limited to, in vivo imaging and brain imaging. Fluorescence imaging performed on humans includes, but is not limited to, fluorescence-guided surgery and in vitro tissue staining.
[0075] The above-mentioned in vivo applications should include a complete set of optical imaging systems that can support in vivo fluorescence imaging, including but not limited to in vivo imagers and various optical fibers, laparoscopy, endoscopes, etc. used in conjunction with human fluorescence imaging.
[0076] In an eighth aspect, the present invention provides an in vitro disease detection method, comprising labeling fluorescent dye molecules on antibodies to detect various diseases through antigen-antibody interactions; or using fluorescent dye molecules as targets to screen nucleic acid aptamers, and using the screened aptamers to perform fluorescent imaging of target nucleic acids and as probes for the detection of various disease markers.
[0077] A ninth aspect of the present invention provides a method for in vivo fluorescence imaging detection or treatment, comprising performing fluorescence-guided surgery or in vitro tissue staining on a human or animal body by fluorescence imaging or fluorescence lifetime imaging;
[0078] Optionally, the optical imaging system includes an imager or various optical fibers, laparoscopy, or endoscopes used in conjunction with fluorescence imaging of the human body or animals. BRIEF DESCRIPTION OF THE DRAWINGS
[0079] Figure 1 shows a molecular rotor 2 (1×10 -5 M) Fluorescence emission intensity graph under different viscosity conditions;
[0080] Figure 2 shows the molecular rotor 2 (1×10 -5 M) Linear relationship between viscosity conditions and fluorescence intensity;
[0081] Figure 3 shows a molecular rotor 9 (1×10 -5 M) Fluorescence emission intensity graph under different viscosity conditions;
[0082] Figure 4 shows a molecular rotor 9 (1×10 -5 M) Linear relationship between viscosity conditions and fluorescence intensity;
[0083] Figure 5 shows the molecular rotor 12 (1×10 -5 M) Fluorescence emission intensity graph under different viscosity conditions;
[0084] Figure 6 shows a molecular rotor 12 (1×10 -5 M) Linear relationship between viscosity conditions and fluorescence intensity;
[0085] Figure 7 shows a molecular rotor 19 (1×10 -5 M) Fluorescence emission intensity graph under different viscosity conditions;
[0086] Figure 8 shows a molecular rotor 19 (1×10 -5 M) Linear relationship between viscosity conditions and fluorescence intensity;
[0087] Figure 9 shows a molecular rotor 40 (1×10 -5 M) Fluorescence emission intensity graph under different viscosity conditions;
[0088] Figure 10 shows a molecular rotor 40 (1×10 -5 M) Linear relationship between viscosity conditions and fluorescence intensity;
[0089] FIG11 shows the photostability test of molecular rotors 6, 12, 20, 40, 42 and comparative molecules 1 and 2;
[0090] Figure 12 shows the molecular rotor 6 (1×10 -5 M) Fluorescence lifetime diagrams under different viscosity conditions;
[0091] Figure 13 shows a molecular rotor 12 (1×10 -5 M) Fluorescence lifetime diagrams under different viscosity conditions;
[0092] Figure 14 shows a molecular rotor 19 (1×10 -5 M) Fluorescence lifetime diagrams under different viscosity conditions;
[0093] Figure 15 shows a molecular rotor 20 (1×10 -5 M) Fluorescence lifetime diagrams under different viscosity conditions;
[0094] FIG16 is a molecular rotor 41 (1×10 -5 M) Fluorescence lifetime diagrams under different viscosity conditions;
[0095] Figure 17 shows the comparative molecule 3 (1×10 -5 M) Fluorescence lifetime diagrams under different viscosity conditions;
[0096] Figure 18 shows the comparative molecule 4 (1×10 -5 M) Fluorescence lifetime diagrams under different viscosity conditions;
[0097] Figure 19 shows molecular rotors 6, 12, 20, 40, 42 and comparison molecules 1 and 2 (1×10 -6 M) Fluorescence background comparison in PBS;
[0098] FIG20 is a diagram showing the specific localization of molecular rotors 34, 35, 39, and 40 in subcellular organelles (lysosomes, mitochondria, cell membranes, endoplasmic reticulum, etc.);
[0099] FIG21 is a fluorescence imaging diagram of target proteins in living cells after the molecular rotors 22, 41 and 42 are specifically bound to the protein tags Halo-Tag or SNAP-Tag.
[0100] FIG22 is a fluorescence imaging diagram of molecular rotors 5, 6, 12, and 19 specifically binding to RNA aptamers for low-abundance RNA.
[0101] FIG. 23 shows molecular rotors 20 , 36 , and 43 used for in vivo tumor fluorescence imaging. DETAILED DESCRIPTION
[0102] The following describes the specific embodiments of the present invention in detail. It should be understood that the specific embodiments described herein are only used to illustrate the present invention and are not intended to limit the present invention.
[0103] Example 1
[0104] Synthesis of Compound 2: Compound 1 (2.0 g, 9.6 mmol) was dissolved in 80 mL of tert-butanol solution, and 4-dimethylaminopyridine (DMAP) (1.2 g, 9.6 mmol) was added. The reaction system was stirred at room temperature for 10 minutes. Di-tert-butyl dicarbonate (6.3 g, 29 mmol) was then added to the reaction system, and the reaction system was stirred at room temperature for another 2 hours. After completion of the reaction, the solvent was removed by filtration under reduced pressure, and the residue was purified by column chromatography to obtain Compound 2 (2.1 g, 85% yield). 1 H-NMR (400MHz, DMSO-d6): δ=7.99 (d, J=1.6Hz, 1H), 7.65 (d, J=1.6Hz, 1H), 1.51 (s, 9H).
[0105] Synthesis of compound 3: Synthesized according to Angew.Chem.Int.Ed.2018,57,15702-15706. 1 H-NMR (400MHz, CDCl3): δ = 8.40 (d, J = 3.7Hz, 1H), 8.37 (d, J = 3.7Hz, 1H), 7.04 (d, J = 2.9Hz, 1H), 6.98 (dd, J = 8.8Hz, 2 .2Hz,1H),6.84(dd,J=9.5H,2.9Hz,1H),6.78(d,J=2.9Hz,1H),3.10(s,6H),1.01(s,9H),0.46(s,6H),0.26(s,6H).
[0106] Synthesis of Molecular Rotor 1: In a 100 mL three-necked flask, compound 2 (0.2 g, 0.76 mmol) was dissolved in THF (50 mL) and cooled to -78°C under nitrogen. After 20 minutes, 1.6 M n-butyllithium (0.47 mL, 0.76 mmol) was added dropwise to the reaction system, and the mixture was kept at -78°C and stirred for 30 minutes. Compound 3 (31 mg, 0.0075 mmol) was then dissolved in THF and added dropwise to the reaction system. After the addition was complete, the reaction system was gradually allowed to return to room temperature and stirred for 2 hours. After completion of the reaction, 2 M HCl solution was added to quench the reaction. The organic phases were extracted with DCM, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The residue was purified by column chromatography to yield the product (23 mg, 66% yield). 1H-NMR (400MHz, CDCl3): δ = 7.9 (d, J = 7.4Hz, 1H), 7.34-7.36 (m, 2H), 7.12 (d, J = 7.6Hz, 1H), 7.09 (d, J = 7.6Hz, 1H ),6.78(d,J=9.3Hz,1H),6.58(d,J=2.4Hz,1H),6.33(d,J=2.9Hz,1H),3.09(s,6H),1.56(s,9H),0.48(s,6H).
[0107] Example 2
[0108] Synthesis of Compound 5: Compound 4 (2.0 g, 9.1 mmol) was dissolved in 50 mL of methanol, and concentrated sulfuric acid (1.5 mL) was added dropwise. The mixture was stirred under reflux overnight. The next day, the solvent was removed by distillation under reduced pressure. The resulting solid was diluted with water (20 mL) and basified with saturated sodium carbonate solution. After extraction with EA, the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product (2.1 g, 82% yield) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CDCl3): δ=7.54(s,1H),3.87(s,3H),2.57(s,3H).
[0109] Synthesis of compound 6: The compound 6 was synthesized according to Chem. Commun., 2011, 47, 4162-4164. 1 H-NMR (400MHz, CDCl3): δ = 8.37 (d, J = 8.8Hz, 2H), 7.04 (d, J = 2.9Hz, 2H), 6.98 (dd, J = 2.2, 8.8Hz, 2H), 1.01 (s, 18H), 0.46 (s, 6H), 0.26 (s, 12H).
[0110] Synthesis of Molecular Rotor 2: In a 100 mL three-necked flask, compound 5 (0.2 g, 0.72 mmol) was dissolved in THF (50 mL) and cooled to -78°C under nitrogen. After 20 minutes, 1.6 M n-butyllithium (0.45 mL, 0.72 mmol) was added dropwise to the reaction system, and the mixture was kept at -78°C and stirred for 30 minutes. Compound 6 (36 mg, 0.0072 mmol) was then dissolved in THF and added dropwise to the reaction system. After the addition was complete, the reaction system was gradually allowed to warm to room temperature and stirred for 2 hours. After completion of the reaction, 2 M HCl solution was added to quench the reaction. The organic phases were extracted with DCM, dried over anhydrous sodium sulfate, and the solvent removed under reduced pressure. The product was purified by column chromatography to obtain 23 mg (72% yield).1 H-NMR (400MHz, CDCl3): δ=7.46-7.27(m,2H),7.12(d,J=7.6Hz,1H),7.09(d,J=7.6Hz,1H),6.85(d, J=9.3Hz,1H),6.78(d,J=2.4Hz,1H),6.63(d,J=2.9Hz,1H),3.96(s,3H),2.01(s,3H),0.48(s,6H).
[0111] Example 3
[0112] Synthesis of compound 7: The compound 7 was synthesized according to the literature Org. Lett. 2009, 11, 14, 3144-3147. 1 H-NMR (400MHz, CDCl3): δ = 7.87 (d, J = 4.2Hz, 1H), 7.13-7.08 (m, 2H).
[0113] Synthesis of compound 8: Synthesized according to Angew.Chem.Int.Ed.2018,57,6910. 1 H-NMR (400MHz, CDCl3): δ = 7.86 (d, J = 4.2Hz, 1H), 7.14-7.06 (m, 2H).
[0114] Synthesis of Compound 9: Compound 8 (2 g, 13 mmol) and 50 mL of acetonitrile were added to a 100 mL dry, single-necked flask. Once dissolved, NBS (2.6 g, 14.5 mmol) and ammonium acetate (51 mg, 0.66 mmol) were added under nitrogen and stirred at room temperature. After the reaction, the resulting solution was distilled off under reduced pressure, extracted with EA / H₂O, washed with saturated NaCl, dried over anhydrous Na₂SO₄, and the organic solvent was removed by distillation under reduced pressure. The crude product was purified by column chromatography to obtain the product in a 69% yield. 1 H-NMR (400MHz, CDCl3): δ=7.84 (d, J=4.8Hz, 1H), 6.99 (dd, J=4.8, 0.4Hz, 1H).
[0115] Synthesis of compound 10: The compound 10 was synthesized according to J.Am.Chem.Soc.2019, 141, 18, 7562-7571 with a yield of 39%. 1 H-NMR (400MHz, CDCl3): δ = 8.40 (d, J = 9.0Hz, 2H), 6.84 (d, J = 9.0, 2.8Hz, 2H), 6.79 (d, J = 2.8Hz, 2H), 3.09 (s, 12H), 0.49 (s, 6H).
[0116] Synthesis of molecular rotor 3: refer to the synthesis method of molecular rotor 1, with a yield of 39%. 1 H-NMR(400 MHz, CD3OD): δ = 12.86 (s, 1H), 7.16 (s, 2H), 6.88 (t, J = 7.5Hz, 2H), 6.81 (t, J = 7.5Hz, 1 H), 6.47 (d, J = 7.5Hz, 2H), 6.08 (d, J = 9.5Hz, 1H), 3.66 (q, J = 6.5Hz, 12H), 0.66 (s, 6H).
[0117] Example 4
[0118] Synthesis of compound 11: refer to the synthesis method of compound 9, with a yield of 56%. 1 H-NMR (400MHz, CDCl3): δ=7.89 (d, J=1.6Hz, 1H), 7.45 (d, J=1.6Hz, 1H).
[0119] Synthesis of compound 12: refer to the synthesis method of compound 2, with a yield of 76%. 1 H-NMR (400MHz, CDCl3): δ=7.86 (d, J=1.6Hz, 1H), 7.43 (d, J=1.6Hz, 1H), 1.53 (s, 9H).
[0120] Synthesis of compound 13: synthesized according to Dalton Trans., 2019, 48, 5665-5673. 1 H-NMR (400MHz, CDCl3): δ = 8.56 (d, J = 9.1Hz, 2H), 6.78 (d, J = 2.5Hz, 2H), 6.74 (dd, J = 2.6, 9.1Hz, 2H), 3.05 (s, 12H).
[0121] Synthesis of compound 14: refer to the synthesis method of molecular rotor 1, with a yield of 65%. 1 H-NMR (400MHz, CDCl3): δ=7.98(d,J=,7.4Hz,1H),7.39(m,2H),7.21(d,J=7.6Hz,1H),7.09(d,J=7.6H z,1H),6.88(d,J=9.3Hz,1H),6.82(d,J=2.4Hz,1H),6.63(d,J=2.9Hz,1H),3.09(s,12H),1.56(s,9H).
[0122] Synthesis of Molecular Rotor 4: Compound 14 (50 mg, 0.082 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and N-Boc-ethylenediamine (14 mg, 0.09 mmol), the condensing agent PyBop (64 mg, 0.12 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. After purification by column chromatography, the resulting solid was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure to obtain the product (40 mg, 82% yield). 1 H-NMR (400MHz, DMSO-d6): δ = 7.98 (d, J = 7.4Hz, 1H), 7.39 (m, 2H), 7.21 (d, J = 7.6Hz, 1H), 7.09 (d, J = 7.6Hz, 1H), 6.88 (d, J=9.3Hz,1H),6.82(d,J=2.4Hz,1H),6.63(d,J=2.9Hz,1H),3.46(t,J=7.8Hz,2H),3.09(s,12H),2.46(t,J=7.7Hz,2H).
[0123] Example 5
[0124] Synthesis of compound 15: refer to the synthesis method of compound 2, with a yield of 65%. 1 H-NMR (400 MHz, DMSO-d6): δ = 7.88 (d, J = 1.6 Hz, 1H), 7.56 (d, J = 1.6 Hz, 1H), 1.51 (s, 9H).
[0125] Synthesis of compound 16: The compound 16 was synthesized according to J.Am.Chem.Soc.2019, 141, 18, 7562-7571 with a yield of 29%. 1 H-NMR (400MHz, CDCl3): δ = 8.27 (dd, J = 7.9, 0.6Hz, 2H), 6.72-6.79 (m, 4H), 3.09 (s, 12H), 1.72 (s, 6H).
[0126] Synthesis of compound 17: refer to the synthesis method of molecular rotor 1, with a yield of 55%. 1H-NMR (400MHz, CDCl3): δ = 7.68 (d, J = 6.9Hz, 1H), 7.29 (m, 2H), 7.10 (d, J = 7.5Hz, 1H), 7.02 (d, J = 6.6Hz, 1H), 6.78(d,J=8.3Hz,1H),6.68(d,J=2.5Hz,1H),6.43(d,J=2.6Hz,1H),3.09(s,12H),1.56(s,9H),1.38(s,6H).
[0127] Synthesis of Molecular Rotor 5: Compound 17 (40 mg, 0.087 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and tert-butyl [2-(2-aminoethoxy)ethyl]carbamate (20 mg, 0.096 mmol), condensing agent PyBop (68 mg, 0.13 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. After purification by column chromatography, the resulting solid was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure to obtain the product (29 mg, 67% yield). 1 H-NMR (400MHz, CDCl3): δ=7.68(d,J=6.9Hz,1H),7.29(m,2H),7.10(d,J=7.5Hz,1H),7.02(d,J=6.6Hz,1H),6.78(d,J=8.3Hz ,1H),6.68(d,J=2.5Hz,1H),6.43(d,J=2.6Hz,1H),3.66(t,J=7.8Hz,4H),3.26(t,J=6.9Hz,4H),3.09(s,12H),1.38(s,6H).
[0128] Example 6
[0129] Synthesis of compound 18: refer to the synthesis method of compound 9, with a yield of 92%. 1 H-NMR (400MHz, DMSO-D6): δ = 10.63 (s, 1H), 8.46 (s, 1H), 7.82 (s, 1H).
[0130] Synthesis of compound 19: refer to the synthesis method of compound 2, with a yield of 95%. 1H-NMR (400MHz, DMSO-D6): δ = 8.44 (s, 1H), 7.84 (s, 1H), 1.42 (s, 9H).
[0131] Synthesis of compound 20: referring to the synthesis method of molecular rotor 1, the yield was 73%. 1 H-NMR (400MHz, CDCl3): δ = 8.35 (dd, J = 7.9, 1.7Hz, 1H), 7.40 (d, J = 7.9Hz, 1H), 7.30 (d, J = 2.8H z,2H),6.93(d,J=9.4Hz,2H),6.74(dd,J=9.5Hz,2H),3.26(s,12H),1.56(s,9H),1.38(s,6H).
[0132] Synthesis of molecular rotor 6: refer to the synthesis method of molecular rotor 5, with a yield of 73%. 1 H-NMR (400MHz, CDCl3): δ = 8.35 (dd, J = 7.9, 1.7Hz, 1H), 7.40 (d, J = 7.9Hz, 1H), 7.30 (d, J = 2.8Hz, 2H), 6.93 (d, J =9.4Hz, 2H), 6.74 (dd, J = 9.5Hz, 2H), 3.75 (t, J = 9.6Hz, 4H), 3.36 (t, J = 9.4Hz, 4H), 3.00 (s, 12H), 1.32 (s, 6H).
[0133] Example 7
[0134] Synthesis of Compound 21: Tellurophene (1 g, 5.6 mmol) and 40 mL of acetonitrile were added to a 100 mL dry, single-necked flask. After the tellurophene dissolved, NBS (1.1 g, 6.2 mmol) and ammonium acetate (43 mg, 0.56 mmol) were added under nitrogen and stirred at room temperature. After the reaction, the resulting solution was distilled off under reduced pressure, extracted with EA / H₂O, washed with saturated NaCl, dried over anhydrous Na₂SO₄, and the organic solvent was distilled off under reduced pressure. The crude product was purified by column chromatography to obtain the product (1.2 g, 80.6% yield). 1 H-NMR (400MHz, CDCl3): δ = 6.98 (s, J = 9.2Hz, 1H), 6.81 (dd, J = 8.6Hz, 1H), 6.74 (d, J = 8.4Hz, 1H).
[0135] Synthesis of Compound 22: Trifluoroacetic anhydride (30 mL, 0.21 mol) was slowly added to a solution of sulfuric acid (9.81 g, 0.1 mol) in an ice bath and dry environment. The mixture was stirred for 3 hours to completely dissolve the sulfuric acid. After the solution turned light brown, Compound 21 (25.9 g, 0.1 mol) was added dropwise to the mixture. After stirring for 10 minutes, cold water was added to the mixture to precipitate a solid. The liquid was removed by distillation under reduced pressure to obtain a crude product. The resulting product was purified by column chromatography to obtain the product (34.8 g, 98% yield). 1 H-NMR (400MHz, CDCl3): δ=7.03 (s, J=7.0Hz, 1H), 6.96 (dd, J=8.2Hz, 1H).
[0136] Synthesis of compound 23: The compound 23 was synthesized according to J. Org. Chem. 2003, 68, 3344-3347, with a yield of 23%. 1 H-NMR (400MHz, CDCl3): δ = 8.42 (d, J = 9.2Hz, 2H), 6.81 (dd, J = 2.4, 9.2Hz, 2H), 6.74 (d, J = 2.4Hz, 2H), 3.11 (s, 12H).
[0137] Synthesis of molecular rotor 7: Refer to the synthesis method of molecular rotor 1, with a yield of 52%. 1 H-NMR (400MHz, CDCl3): δ = 8.67 (s, J = 8.5Hz, 1H), 8.56 (d, J = 9.1Hz, 2H), 7.60 (s, J=6.5Hz,1H),6.83(dd,J=2.6,9.2Hz,2H),6.76(d,J=2.4Hz,2H),3.07(s,12H).
[0138] Example 8
[0139] Synthesis of compound 24: refer to the synthesis method of compound 9, with a yield of 65%. 1 H-NMR (400MHz, DMSO-d6): δ=12.97(s,1H),12.75(s,1H),7.82(s,1H).
[0140] Synthesis of compound 25: refer to the synthesis method of compound 2, with a yield of 76%. 1 H-NMR (400MHz, DMSO-d6): δ=12.86(s,1H),7.86(s,1H),1.51(s,9H).
[0141] Synthesis of compound 26: The compound 26 was synthesized according to the literature Chem. Eur. J. 2017, 23, 12114-12119, with a yield of 72%. 1 H-NMR (400MHz, CDCl3): δ = 8.42 (d, J = 9.0Hz, 2H), 6.80 (dd, J = 9.1, 2.8Hz, 2H), 6.72 (d, J = 2.8Hz, 2H), 3.08 (s, 12H), 0.60 (s, 6H).
[0142] Synthesis of compound 27: referring to the synthesis method of molecular rotor 1, the yield was 34%. 1 H-NMR (400MHz, CDCl3): δ=7.85 (dd, J=6.8, 1.9Hz, 1H), 7.54 (d, J=7.6, 2.2Hz, 1H), 7.06 (d, J=2. 8Hz, 2H), 6.73 (d, J = 9.4Hz, 2H), 6.64 (dd, J = 9.2Hz, 1H), 3.06 (s, 12H), 1.56 (s, 9H), 0.68 (s, 6H).
[0143] Synthesis of Molecular Rotor 8: Compound 27 (50 mg, 0.096 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and tert-butyl 2-(2-(2-aminoethoxy)ethoxy)ethylcarbamate (26 mg, 0.011 mmol), condensing agent PyBop (75 mg, 0.14 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. After purification by column chromatography, the resulting solid was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure to obtain the product (40 mg, 70% yield). 1 H-NMR (400MHz, CDCl3): δ = 7.85 (dd, J = 6.8, 1.9Hz, 1H), 7.54 (d, J = 7.6, 2.2Hz, 1H), 7.06 (d, J = 2.8Hz, 2H), 6.73 (d, J = 9.4Hz, 2H), 6.64 (d d,J=9.2Hz,1H),3.75(t,J=9.6Hz,4H),3.66(t,J=9.4Hz,4H),3.35(t,J=8.7Hz,2H),3.26(t,J=9.4Hz,2H),3.06(s,12H),0.68(s,6H).
[0144] Example 9
[0145] Synthesis of compound 28: The compound was synthesized according to J.Am.Chem.Soc.2012, 134, 5029-5031 and J.Am.Chem.Soc.2019, 141, 7562-7571, with a yield of 22%. 1 H-NMR (400MHz, CDCl3): δ = 7.42 (d, J = 9.0Hz, 2H), 6.80 (dd, J = 9.1, 2.8Hz, 2H), 3.47 (t, J = 8.1Hz, 4H), 3.05 (t, J = 8.1Hz, 4H), 2.90 (s, 6H), 0.44 (s, 6H).
[0146] Synthesis of compound 29: referring to the synthesis method of molecular rotor 1, the yield was 82%. 1 H-NMR (400MHz, CDCl3): δ = 7.9 (d, J = 7.4Hz, 1H), 7.34-7.36 (m, 2H), 6.80 (dd, J = 9.1, 2.8Hz, 2H), 6 .06(s,2H),3.34(t,J=7.8Hz,4H),3.09(t,J=8.0Hz,4H),2.90(s,6H),1.56(s,9H),0.44(s,6H).
[0147] Synthesis of Molecular Rotor 9: Compound 29 (30 mg, 0.06 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DCM, and NHS (10 mg, 0.09 mmol), EDC (17 mg, 0.09 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 2 hours. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the product was purified by column chromatography to obtain 25 mg of the product (76% yield). 1 H-NMR (400MHz, CDCl3): δ=7.9 (d, J=7.4Hz, 1H), 7.34-7.36 (m, 2H), 6.80 (dd, J=9.1, 2.8Hz, 2H), 6.06 ( s,2H),3.34(t,J=7.8Hz,4H),3.09(t,J=8.0Hz,4H),2.90(s,6H),2.56(t,J=7.8Hz,4H),0.44(s,6H).
[0148] Example 10
[0149] Synthesis of compound 30: refer to the synthesis method of compound 9, with a yield of 72%. 1H-NMR (400MHz, DMSO-D6): δ = 12.63 (s, 1H), 9.46 (s, 1H), 7.82 (d, J = 7.6, 2.3Hz, 1H), 6.95 (d, J = 8.6, 2.4Hz, 1H).
[0150] Synthesis of compound 31: refer to the synthesis method of compound 2, with a yield of 88%. 1 H-NMR (400MHz, DMSO-D6): δ = 9.44 (s, 1H), 7.79 (d, J = 7.6, 2.3Hz, 1H), 6.96 (d, J = 8.6, 2.4Hz, 1H), 1.42 (s, 9H).
[0151] Synthesis of compound 32: Synthesized according to the literature Chem.Eur.J.2020, 26, 7912-7917, with a yield of 61%. 1 H-NMR (400MHz, CDCl3): δ = 8.31 (dd, J = 8.9, 5.8Hz, 2H), 7.64-7.58 (m, 2H), 7.37-7.28 (m, 3H), 7 .00(dd,J=14.7,2.4Hz,2H),6.72(dd,J=9.2,2.4Hz,2H),3.43-3.32(m,8H),2.03-1.99(m,8H).
[0152] Synthesis of compound 33: referring to the synthesis method of molecular rotor 1, the yield was 78%. 1 H-NMR (400MHz, CDCl3): δ = 8.40 (dd, J = 8.8, 5.8Hz, 2H), 7.87 (s, 1H), 7.61 (m, 2H), 7.39 (s, 1H), 7 .34(m,3H),7.02(dd,J=14.6,2.4Hz,2H),6.72(dd,J=9.2,2.4Hz,2H),3.40(m,8H),2.01(m,8H).
[0153] Synthesis of Molecular Rotor 10: Compound 33 (25 mg, 0.041 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and tert-butyl 9-amino-4,7-dioxanononanoate (11 mg, 0.045 mmol), the condensing agent PyBop (32 mg, 0.062 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. After purification by column chromatography, the resulting solid was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure to obtain the product (19.3 mg, 66% yield). 1 H-NMR (400MHz, CDCl3): δ = 8.35 (s, 1H), 8.25 (s, 1H), 8.02 (d, J = 7.6Hz, 1H), 7.34 (m, 3H), 7.08 (dd, J = 14.6, 2.4Hz, 2H), 6.76 (dd, J = 9.2, 2.4Hz, 2H), 7.22(d,J=7.3Hz,1H),7.16(s,2H),6.62(s,2H),3.83(t,J=8.1Hz,4H),3 .23(s,2H),2.93(t,J=8.1Hz,4H),2.10(s,2H),3.40(m,8H),2.01(m,8H).
[0154] Example 11
[0155] Synthesis of compound 34: refer to the synthesis method of compound 2, with a yield of 65%. 1 H-NMR (400MHz, DMSO-d6): δ = 7.82 (s, 1H), 1.51 (s, 9H).
[0156] Synthesis of compound 35: referring to the synthesis method of molecular rotor 1, the yield was 78%. 1 H-NMR (400MHz, CDCl3): δ = 8.25 (d, J = 8.4Hz, 1H), 7.68 (d, J = 8.4Hz, 1H), 7.61 (t, J = 7. 2Hz,1H),7.03(d,J=7.2Hz,2H),6.92(s,2H),1.63(s,9H),1.37(s,12H),0.45(s,6H).
[0157] Synthesis of Molecular Rotor 11: Compound 35 (257 mg, 0.54 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in 100 mL of anhydrous DCM, and a catalytic amount of DMF (3 drops) was added. The reaction system was cooled to 0°C and stirred for 5 minutes. Then, thionyl chloride (77 mg, 6.5 mmol) was added dropwise and the reaction was stirred at 85°C for 5 hours. The resulting mixture was rotary evaporated to remove the solvent to obtain the product in a 79% yield. 1 H-NMR (400MHz, CDCl3): δ = 8.36 (d, J = 8.4Hz, 1H), 7.78 (d, J = 8.4Hz, 1H), 7.72 (t, J = 7.2Hz, 1H), 7.14 (d, J = 7.2Hz, 2H), 6.88 (s, 2H), 1.39 (s, 12H), 0.44(s,6H).
[0158] Example 12
[0159] Synthesis of compound 36: referring to the synthesis method of molecular rotor 1, the yield was 55%. 1 H-NMR (400MHz, CDCl3): δ = 7.80 (d, J = 6.9Hz, 1H), 7.30 (m, 2H), 7.21 (d, J = 7.5Hz, 1H), 7.13 (d, J = 6.6Hz, 1H), 6.89(d,J=8.3Hz,1H),6.79(d,J=2.5Hz,1H),6.54(d,J=2.6Hz,1H),3.10(s,12H),1.67(s,9H),1.49(s,6H).
[0160] Synthesis of Molecular Rotor 12: Compound 36 (40 mg, 0.084 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and mercapto-triethylene glycol-amino (19 mg, 0.093 mmol), condensing agent PyBop (66 mg, 0.13 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product (32, 62% yield) was obtained after purification by column chromatography. 1H-NMR (400MHz, CDCl3): δ = 8.36 (s, 1H), 8.25 (d, J = 7.5Hz, 1H), 7.89 (d, J = 6.9H z,1H),7.30(s,1H),7.21(d,J=7.5Hz,1H),7.13(d,J=6.6Hz,1H),6.89(d,J=8 .3Hz,1H),6.79(d,J=2.5Hz,1H),6.54(d,J=2.6Hz,1H),3.83(t,J=8.1Hz,4H) ,3.23(s,2H),3.10(s,12H),2.93(t,J=8.1Hz,4H),2.10(s,2H),1.49(s,6H).
[0161] Example 13
[0162] Synthesis of Compound 37: 5-(Thiophen-2-yl)thiophene-2-carbonitrile (4.77 g, 30 mmol) was dissolved in 20 mL of DMF. NBS (5.34 g, 30 mmol) was added portionwise and stirred overnight. After completion of the reaction, the reaction system was poured into cold water. The resulting solid was collected by filtration, washed with water, and dried to obtain Compound 37 in a 95% yield. 1 H-NMR (400MHz, DMSO-d6): δ = 7.88 (d, J = 3.9Hz, 1H), 7.41 (d, J = 3.9Hz, 1H), 7.34 (d, J = 3.9Hz, 1H), 7.26 (d, J = 3.9Hz, 1H).
[0163] Synthesis of compound 38: The compound 38 was synthesized according to Chem. Commun., 2016, 52, 12290-12293, with a yield of 35%. 1 H-NMR (400MHz, CDCl3): δ = 8.28 (tq, J = 6.8, 2.6, 2.0Hz, 2H), 7.23 (ddd, J = 15.2, 4.1, 2.6Hz, 2H), 6.91 (ddd, J = 9.1, 4.1, 2.6Hz, 2H), 3.90 (ddd, J =9.9,5.6,2.8Hz,2H),3.21-3.09(m,12H),1.24-1.11(m,3H).
[0164] Synthesis of compound 39: referring to the synthesis method of molecular rotor 1, the yield was 49%. 1H-NMR (400MHz, DMSO-d6): δ = 7.65-7.37 (m, 5H), 7.18 (t, J = 7.8Hz, 1H), 7.04 (td, J = 10.3, 6.8Hz, 2H), 6.83(dd,J=9.7,2.8Hz,2H), 4.09(dp,J=9.6,7.2Hz,2H), 3.38(s,12H), 1.24(dt,J=18.1,7.0Hz,3H).
[0165] Synthesis of Molecular Rotor 13: Compound 39 (20 mg, 0.038 mmol) obtained above was dissolved in 9 M HCl (2 mL). The reaction system was heated under reflux with stirring overnight. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the resulting solid was recrystallized to obtain the pure product (16 mg, 87% yield). 1 H-NMR (400MHz, DMSO-d6): δ=7.53-7.34(m,3H),7.24(d,J=14.7Hz,2H),7.12(d,J=7.3Hz,1H),6.90-6.70(m,4H),3.30(s,12H).
[0166] Example 14
[0167] Synthesis of Compound 40: To a 100 mL three-necked flask, 2-pyrroleboronic acid (0.93 g, 8.4 mmol), 4-bromophenyl isothiocyanate (1.5 g, 7 mmol), Na2CO3 (1.86 g, 17.5 mmol), and 50 mL of a mixed solvent (toluene:ethanol:water = 1:1:1) were added. Tetrakis(triphenylphosphine)palladium (0.4 g, 0.35 mmol) was then added. The reaction system was heated to 80°C under nitrogen and stirred at reflux for 6 hours. After completion of the reaction, the reaction system was cooled to room temperature, quenched with NH4Cl, and extracted with EA. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product (1.23 g, 88% yield) was obtained by column chromatography. 1 H-NMR (400MHz, CDCl3): δ = 7.58-7.56 (m, 1H), 7.41-7.34 (m, 3H), 7.29-7.26 (m, 2H), 7.13 (t, J = 4.4Hz, 1H).
[0168] Synthesis of compound 41: refer to the synthesis method of compound 9, with a yield of 74%. 1H-NMR (400MHz, CDCl3): δ=7.47-7.37(m,3H),7.27(d,J=7.8Hz,1H),7.16(s,1H),7.14(d,J=8.0Hz,1H).
[0169] Synthesis of compound 42: The compound 42 was synthesized according to the literature Chem. Eur. J. 2015, 21, 16754-16758, with a yield of 38%. 1 H-NMR (400MHz, CDCl3): δ = 8.29 (d, J = 9.0Hz, 1H), 8.26 (d, J = 9.0Hz, 1H), 7.26 (d, J = 3.0Hz, 1H), 7.21 (d, J = 2. 7Hz, 1H), 6.90 (dd, J = 9.0, 2.4Hz, 2H), 3.51 (q, J = 7.2Hz, 8H), 1.88 (d, J = 13.4Hz, 3H), 1.25 (t, J = 7.2Hz, 12H).
[0170] Synthesis of molecular rotor 14: refer to the synthesis method of molecular rotor 1, with a yield of 20%. 1 H-NMR (400MHz, CDCl3): δ = 7.78-7.75 (m, 2H), 7.66-7.64 (m, 3H), 7.42-7.38 (m, 2H), 7.26 (d, J = 2.4Hz, 1H), 6. 99(d,J=2.4Hz,2H),6.87(d,J=2.4Hz,2H),3.88-3.78(m,8H),2.06(d,J=13.6Hz,3H),1.38(t,J=6.0Hz,12H).
[0171] Example 15
[0172] Synthesis of compound 43: refer to the synthesis method of compound 40, with a yield of 84%. 1 H-NMR (400MHz, DMSO-d6): δ = 12.25 (s, 1H), 7.71 (s, 1H), 7.58 (s, 1H), 7.34 (s, 1H), 6.51-6.49 (m, 1H).
[0173] Synthesis of compound 44: The compound was synthesized according to ACS Appl. Mater. Interfaces 2016, 8, 22953-22962, with a yield of 38%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.00 (d, J = 9.0Hz, 2H), 7.09 (m, 4H), 3.14 (s, 12H).
[0174] Synthesis of compound 45: refer to the synthesis method of molecular rotor 1, with a yield of 20%. 1 H-NMR (400MHz, CDCl3): δ = 7.65 (m, 3H), 7.4 (d, J = 4.8Hz, 2H), 7.37 (t, J = 7.8Hz, 2H), 7.22 (t, J = 7.8Hz, 2H), 7.08 (s, 1H), 3.58 (s, 12H).
[0175] Synthesis of Molecular Rotor 15: Compound 45 (20 mg, 0.044 mmol) and 50 mL of acetonitrile were added to a 100 mL dry, single-necked flask. After dissolution, NIS (11 mg, 0.049 mmol) and ammonium acetate (0.17 mg, 0.002 mmol) were added under nitrogen and stirred at room temperature. After completion of the reaction, the resulting solution was removed by vacuum distillation, extracted with EA / H₂O, washed with saturated NaCl, dried over anhydrous Na₂SO₄, and the organic solvent was removed by vacuum distillation. The crude product was purified by column chromatography with a yield of 89%. 1 H-NMR (400MHz, CDCl3): δ = 7.59 (d, J = 2.4Hz, 2H), 7.28 (s, 1H), 7.14 (m, 3H), 7.05 (dd, J = 2.4, 7.8Hz, 2H), 6.07 (d, J = 12.6Hz, 1H), 3.55 (s, 12H).
[0176] Example 16
[0177] Synthesis of compound 46: refer to the synthesis method of compound 40, with a yield of 85%. 1 H-NMR (400MHz, CDCl3): δ = 7.86 (s, 1H), 7.66 (d, J = 3.9Hz, 1H), 7.35 (d, J = 4.4Hz, 1H), 7.25 (d, J = 3.9Hz, 1H), 7.08 (t, J = 4.4Hz, 1H), 1.53 (s, 9H).
[0178] Synthesis of compound 47: refer to the synthesis method of compound 9, with a yield of 78%. 1 H-NMR (400MHz, CDCl3): δ=7.66 (d, J=3.9Hz, 1H), 7.22 (d, J=3.8Hz, 1H), 7.19 (d, J=3.9Hz, 1H), 7.02 (d, J=3.8Hz, 1H), 1.54 (s, 9H).
[0179] Synthesis of compound 48: referring to the synthesis method of molecular rotor 1, the yield was 65%. 1H-NMR (400MHz, CDCl3): δ=7.90(d,J=2.9Hz,2H),7.55-7.38(m,5H),7.14(d,J=7.3Hz,1H), 6.91(dd,J=10.3,2.9Hz,2H),3.23(s,12H),1.60(s,9H).
[0180] Synthesis of Molecular Rotor 16: Compound 48 was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The solid was then dissolved in 2 mL of methanol, and aqueous hydrogen peroxide (30-35%) was slowly added dropwise in portions. The mixture was stirred vigorously at room temperature. Once the solution changed color, the reaction mixture was immediately diluted with 3 mL of 0.1% aqueous TFA. The product was then purified by column chromatography in a 20% yield. 1 H-NMR (400MHz, CDCl3): δ=8.14(d,J=2.9Hz,2H),7.55-7.37(m,3H),7.26(d,J =9.5Hz,2H),7.14(d,J=8.0Hz,1H),6.92(dd,J=9.5,2.9Hz,2H),3.44(s,12H).
[0181] Example 17
[0182] Synthesis of compound 49: refer to the synthesis method of compound 9, with a yield of 89%. 1 H-NMR (400MHz, DMSO-d6): δ = 13.01 (s, 1H), 8.64 (s, 1H), 8.01 (d, J = 5.6Hz, 1H), 7.98-7.92 (m, 1H), 7.55 (d, J = 5.6Hz, 1H).
[0183] Synthesis of compound 50: refer to the synthesis method of compound 2, with a yield of 92%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.62 (s, 1H), 8.01 (d, J = 5.6Hz, 1H), 7.95 (m, 1H), 7.52 (d, J = 5.6Hz, 1H), 1.54 (s, 9H).
[0184] Synthesis of compound 51: The compound was synthesized according to Angew.Chem.Int.Ed.2017, 56, 4197-4200 and J.Am.Chem.Soc.2012, 134, 5029-5031, with a yield of 18%. 1H-NMR (400MHz, CDCl3): δ = 7.41 (m, 2H), 7.22 (s, 2H), 3.60 (t, J = 5.1Hz, 4H), 3.33 (s, 6H), 2.48 (t, J = 5.9Hz, 4H), 1.91 (dt, J = 5.9, 5.1Hz, 4H).
[0185] Synthesis of compound 52: referring to the synthesis method of molecular rotor 1, the yield was 65%. 1 H-NMR (400MHz, CD3OD): δ = 7.43-7.26 (m, 3H), 7.22 (d, J = 7.5Hz, 1H), 7.08 (d, J = 2.8Hz, 2H), 6.42 (d, J = 2.8Hz, 1H), 6.39 (d,J=2.8Hz,1H),3.64(t,J=5.2Hz,4H),3.35(s,6H),2.49(t,J=5.8Hz,4H),1.92(dt,J=5.9,5.1Hz,4H),1.54(s,9H).
[0186] Synthesis of molecular rotor 17: refer to the synthesis method of molecular rotor 4, with a yield of 56%. 1 H-NMR (400MHz, CD3OD): δ = 7.45-7.28 (m, 3H), 7.20 (d, J = 7.5Hz, 1H), 7.06 (d, J = 2.8Hz, 2H), 6.40 (d, J = 2.8Hz, 1H), 6.36 (d, J = 2.8Hz, 1H), 3.65 (t,J=5.2Hz,4H),3.46(t,J=7.8Hz,2H),3.35(s,6H),2.49(t,J=5.8Hz,4H),2.46(t,J=7.7Hz,2H),1.92(dt,J=5.9,5.1Hz,4H),1.54(s,9H).
[0187] Example 18
[0188] Synthesis of compound 54: Synthesized according to Angew.Chem.Int.Ed.2017, 56, 4197-420, with a yield of 20%. 1 H-NMR (400MHz, CDCl3): δ = 8.26 (d, J = 9.0Hz, 2H), 7.21 (d, J = 2.7Hz, 2H), 6.90 (d, J = 2.4Hz, 2H), 3.51 (q, J = 7.2Hz, 8H), 1.25 (t, J = 7.2Hz, 12H).
[0189] Synthesis of molecular rotor 18: referring to the synthesis method of molecular rotor 1, the yield was 72%.1 H-NMR (400MHz, CDCl3): δ = 7.62 (d, J = 3.0Hz, 1H), 7.36 (d, J = 7.0Hz, 1H), 7.25 (s, 1H), 7.03 (d, J = 7.4Hz, 1H), 6.95 (s,1H),6.92(s,1H),6.46(d,J=2.9Hz,1H),6.43(d,J=3.0Hz,1H),3.48(q,J=7.2Hz,8H),1.26(t,J=7.2Hz,12H).
[0190] Example 19
[0191] Synthesis of compound 55: refer to the synthesis method of compound 2, with a yield of 87%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.62 (s, 1H), 8.01 (d, J = 5.6Hz, 1H), 7.95 (m, 1H), 1.54 (s, 9H).
[0192] Synthesis of compound 56: The compound 56 was synthesized according to J. Am. Chem. Soc. 2012, 134, 5029-5031, with a yield of 17%. 1 H-NMR (400MHz, CDCl3): δ = 8.21 (s, 2H), 6.51 (s, 2H), 3.47 (t, J = 8.1Hz, 4H), 3.05 (t, J = 8.1Hz, 4H), 2.90 (s, 6H), 0.44 (s, 6H).
[0193] Synthesis of compound 57: referring to the synthesis method of molecular rotor 1, the yield was 36%. 1 H-NMR (400MHz, CD3OD): δ = 8.05 (s, 1H), 8.02 (d, J = 7.3Hz, 2H), 7.22 (d, J = 7.3Hz, 1H), 7.16 (s, 1H), 6.62 ( s,2H),3.83(t,J=8.1Hz,4H),3.23(s,6H),2.93(t,J=8.1Hz,4H),1.50(s,9H),0.58(s,3H),0.56(s,3H).
[0194] Synthesis of Compound 58: Following the synthesis of Molecular Rotor 8, the resulting molecule (0.2 g, 0.34 mmol) was dissolved in 50 mL of DCM. A catalytic amount of dimethylaminopyridine (DMAP) and maleic anhydride (33 mg, 0.34 mmol) were added, and the reaction system was stirred for 2 hours. After completion of the reaction, the mixture was extracted with a DCM / NaHCO₃ aqueous solution, and the aqueous phase was acidified to pH 3 with dilute hydrochloric acid. The combined organic phases were dried over anhydrous Na₂SO₄, and the organic solvent was removed by distillation under reduced pressure. The crude product was purified by column chromatography with a yield of 47%. 1 H-NMR (400MHz, CD3OD): δ = 9.78 (s, 1H), 8.05 (s, 1H), 8.02 (d, J = 7.3Hz, 2H), 7.22 (d, J = 7.3Hz, 1H), 7.16 (s, 1H), 6.62 (s, 2H), 6.44- 6.26(dd,J=13.1Hz,2H),3.83(t,J=8.1Hz,4H),3.68-3.55(m,10H),3.32(t,J=5.1Hz,2H),3.23(s,6H),2.93(t,J=8.1Hz,4H),0.57 (s,6H).
[0195] Synthesis of Molecular Rotor 19: Compound 58 (0.18 g, 0.27 mmol) and sodium acetate (0.11 g, 1.3 mmol) were added to 10 mL of acetic anhydride. After stirring at 120°C for 45 minutes, the solvent was removed by distillation under reduced pressure. The mixture was extracted with DCM, and the combined organic phases were dried over anhydrous NaSO. The crude product was purified by column chromatography with a yield of 81%. 1 H-NMR (400MHz, CD3OD): δ = 8.10 (s, 1H), 8.05 (d, J = 7.3Hz, 2H), 7.31 (d, J = 7.3Hz, 1H), 7.27 (s, 1H), 6.69 (s, 2H), 6.25 (dd, J = 13 .1Hz,2H),3.83(t,J=8.1Hz,4H),3.75-3.47(m,10H),3.32(t,J=5.1Hz,2H),3.23(s,6H),2.93(t,J=8.1Hz,4H),0.57(s,6H).
[0196] Example 20
[0197] Synthesis of compound 59: refer to the synthesis method of compound 9, with a yield of 92%. 1H-NMR (400MHz, CDCl3): δ = 13.02 (s, 1H), 8.30-8.28 (m, 1H), 8.10 (dd, J = 8.4, 1.6Hz, 1H), 7.89 (d, J = 8.4Hz, 1H).
[0198] Synthesis of compound 60: refer to the synthesis method of compound 2, with a yield of 95%. 1 H-NMR (400MHz, CDCl3): δ = 8.23-8.16 (m, 2H), 7.79 (d, J = 1.8Hz, 1H), 1.89 (s, 9H).
[0199] Synthesis of compound 61: The compound 61 was synthesized according to J.Am.Chem.Soc.2012, 134, 5029-5031, with a yield of 37%. 1 H-NMR (400MHz, CD3OD): δ = 7.41 (s, 2H), 7.17 (s, 2H), 5.59 (s, 2H), 3.28 (s, 6H), 2.05 (s, 6H), 1.52 (s, 12H), 0.53 (s, 6H).
[0200] Synthesis of compound 62: refer to the synthesis method of molecular rotor 1, with a yield of 50%. 1 H-NMR (400MHz, CD3OD): δ = 7.52-7.37 (m, 2H), 7.14 (d, J = 7.3Hz, 1H), 6.75 (s, 2H), 5.51 (s, 2H) ,3.29(s,6H),2.05(s,3H),1.58(s,9H),1.53(s,6H),1.49(s,6H),0.61(s,3H),0.59(s,3H).
[0201] Synthesis of Molecular Rotor 20: Compound 62 (50 mg, 0.078 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and 2-methoxyethylamine (6.5 mg, 0.086 mmol), the condensing agent PyBop (61 mg, 0.12 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product (31 mg, 62% yield) was obtained after purification by column chromatography. 1H-NMR (400MHz, CD3OD): δ = 7.38-7.23 (m, 2H), 7.04 (s, 2H), 7.00-6.96 (m, 1H), 6.59 (s, 2H), 3.72 (t, J = 8.3Hz, 4H), 3.67 (t, J = 8.3Hz, 2H),3.53(s,3H)3.13(s,6H),3.07(t,J=8.2Hz,2H),2.04(s,3H),1.59(s,9H),1.54(s,6H),1.38(s,6H),0.48(s,3H),0.45(s,3H).
[0202] Example 21
[0203] Synthesis of compound 64: The compound 64 was synthesized according to J.Am.Chem.Soc.2012, 134, 5029-5031, with a yield of 53%. 1 H-NMR (400MHz, CD3OD): δ = 7.15 (s, 2H), 6.75 (s, 2H), 3.18 (t, J = 5.9Hz, 4H), 2 .85(s,6H),2.56(t,J=6.6Hz,4H),1.90(dt,J=6.6,5.9Hz,4H),0.44(s,6H).
[0204] Synthesis of compound 65: referring to the synthesis method of molecular rotor 1, the yield was 16%. 1 H-NMR (400MHz, CD3OD): δ = 12.08 (s, 1H), 7.49 (s, 1H), 7.22 (s, 2H), 7.08 (d, J = 7.3Hz, 1H), 6.68 (s, 2H), 3.60 ( t,J=5.1Hz,4H),3.33(s,6H),2.48(t,J=5.9Hz,4H),1.91(dt,J=5.9,5.1Hz,4H),0.57(s,3H),0.55(s,3H).
[0205] Synthesis of compound 66: referring to the synthesis method of molecular rotor 11, the yield was 68%. 1 H-NMR (400MHz, CD3OD): δ = 12.05 (s, 1H), 7.50 (s, 1H), 7.31 (s, 2H), 7.10 (d, J = 7.3Hz, 1H), 6.72 (s, 2H), 3.59 ( t,J=5.1Hz,4H),3.29(s,6H),2.52(t,J=5.9Hz,4H),1.91(dt,J=5.9,5.1Hz,4H),0.56(s,3H),0.54(s,3H).
[0206] Synthesis of Molecular Rotor 21: Compound 66 (80 mg, 0.17 mmol) was dissolved in 20 mL of anhydrous THF and added dropwise to a pressure bottle containing potassium thiocyanate (25 mg, 0.25 mmol). The mixture was heated at reflux at 60°C for approximately 2 hours. After completion of the reaction, the solvent was removed by rotary evaporation, and the product was extracted with DCM. The combined organic phases were dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography to obtain the product (60 mg, 72% yield). 1 H-NMR (400MHz, CD3OD): δ = 12.08 (s, 1H), 7.68 (s, 1H), 7.30 (s, 2H), 7.21 (d, J = 7.3Hz, 1H), 6.70 (s, 2H), 3.59 ( t,J=5.1Hz,4H),3.31(s,6H),2.49(t,J=5.9Hz,4H),1.89(dt,J=5.9,5.1Hz,4H),0.58(s,3H),0.54(s,3H).
[0207] Example 22
[0208] Synthesis of compound 67: The compound was synthesized according to J.Am.Chem.Soc.2012, 134, 5029-5031, with a yield of 27%. 1 H-NMR (400MHz, DMSO-D6): δ = 7.23 (d, J = 6.56Hz, 2H), 6.87 (s, 2H), 3.60 (m, 4H), 3.24 (m, 4H), 3.01 (m, 4H), 1.21 (t, J = 6.99Hz, 6H).
[0209] Synthesis of compound 68: referring to the synthesis method of molecular rotor 1, the yield was 36%. 1 H-NMR (400MHz, DMSO-D6): δ = 8.23 (d, J = 7.01Hz, 1H), 7.91 (t, J = 7.52Hz, 1H), 7.82 (t, J = 7.66Hz, 1H), 7.48 ( d,J=7.56Hz,1H),6.78(s,2H),3.66(m,4H),3.29(m,4H),3.06(m,4H),1.56(s,9H),1.24(t,J=7.05Hz,6H).
[0210] Synthesis of Molecular Rotor 22: Compound 68 (35 mg, 0.059 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and 3-chloropropylamine (6 mg, 0.065 mmol), the condensing agent PyBop (46 mg, 0.089 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography (24 mg, 66% yield). 1 H-NMR (400MHz, CD3OD): δ = 8.62 (s, 1H), 8.12 (s, 1H), 7.64 (m, 2H), 7.23 (d, J = 6.5Hz, 1H), 6.85 (s, 1H), 5.93 (s, 1H), 4. 60(m,4H),4.12(m,4H)3.82(m,4H),3.75(m,2H),3.24(t,J=6.6Hz,2H),3.04(t,J=6.5Hz,2H),1.21(t,J=6.99Hz,6H).
[0211] Example 23
[0212] Synthesis of compound 69: The compound 69 was synthesized according to J.Am.Chem.Soc.2014, 136, 254-264, with a yield of 83%. 1 H-NMR (400MHz, CDCl3): δ = 8.05 (d, J = 8.5Hz, 2H), 7.58 (d, J = 8.5Hz, 2H), 7.17 (d, J = 3.9Hz, 1H), 7.08 (d, J = 3.9Hz, 1H), 3.94 (s, 3H).
[0213] Synthesis of molecular rotor 23: refer to the synthesis method of molecular rotor 2, with a yield of 62%. 1 H-NMR (400MHz, CDCl3): δ = 7.94 (dt, J = 7.8, 1.0 Hz, 1H), 7.80 (td, J = 7.8, 1.0 Hz, 1H), 7.67 (td, J = 7.8, 1.0 Hz, 2H), 7.38 (dt, J = 7. 8,1.0Hz,2H),7.23(d,J=2.4Hz,2H),6.83(d,J=8.8Hz,2H),6.76(dd,J=8.8,2.4Hz,2H),3.92(s,3H),0.64(s,3H),0.56(s,3H).
[0214] Example 24
[0215] Synthesis of compound 70: refer to the synthesis method of compound 2, with a yield of 85%. 1 H-NMR (400MHz, CDCl3): δ = 7.54 (s, 1H), 2.57 (s, 3H), 1.56 (s, 9H).
[0216] Synthesis of compound 71: refer to the synthesis method of compound 40, with a yield of 95%. 1 H-NMR (400 MHz, CDCl3): δ = 7.94 (s, 1H), 7.21 (d, J = 3.5Hz, 1H), 6.56 (d, J = 3.4Hz, 1H), 3.91 (s, 3H), 1.74 (s, 9H).
[0217] Synthesis of compound 72: refer to the synthesis method of compound 9, with a yield of 89%. 1 H-NMR (400MHz, CDCl3): δ = 7.82 (s, 1H), 7.76 (dd, J = 8.3, 2.6Hz, 1H), 2.56 (s, 3H), 1.75 (s, 9H).
[0218] Synthesis of compound 73: The compound was synthesized according to J.Am.Chem.Soc.2012, 134, 5029-5031, with a yield of 20%. 1 H-NMR (400MHz, CD3OD): δ = 7.15 (s, 2H), 7.02 (s, 2H), 3.60 (t, J = 5.8Hz, 4H), 3.48 (t, J = 5.9Hz, 4H), 3.18 (t, J = 5.9Hz, 4H), 2.85 (s, 6H), 0.60 (s, 6H).
[0219] Synthesis of Molecular Rotor 24: Following the synthesis of Molecular Rotor 1, the resulting compound was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure, and the product was purified by column chromatography with a yield of 52%. 1 H-NMR (400MHz, CD3OD): δ=7.49-7.32(m,3H),7.22(s,1H),7.08(d,J=7.3Hz,1H),6.68(s,1H),3.68(t,J=5. 9Hz,4H),3.52(t,J=5.9Hz,4H),3.23(t,J=5.9Hz,4H),2.19(s,3H),1.12(s,6H),0.55(s,3H),0.57(s,3H).
[0220] Example 25
[0221] Synthesis of compound 74: refer to the synthesis method of compound 40, with a yield of 92%. 1 H-NMR (400MHz, CDCl3): δ = 7.68 (s, 1H), 7.49-7.32 (m, 4H), 7.01 (d, J = 8.3Hz, 1H), 6.82 (d, J = 8.3Hz, 1H).
[0222] Synthesis of compound 75: refer to the synthesis method of compound 9, with a yield of 85%. 1 H-NMR (400MHz, CDCl3): δ = 7.52-7.36 (m, 4H), 7.05 (d, J = 8.1Hz, 1H), 6.87 (d, J = 8.2Hz, 1H).
[0223] Synthesis of compound 76: The compound was synthesized according to Dyes and Pigments 99 (2013) 1132-1136, with a yield of 20%. 1 H-NMR (400MHz, CD3OD): δ = 6.92 (s, 2H), 6.78 (s, 2H), 3.57 (s, 8H), 3.4 (t, J = 5.9Hz, 8H), 1.12 (t, J = 6.9Hz, 12H), 0.66 (s, 6H).
[0224] Synthesis of compound 77: referring to the synthesis method of molecular rotor 1, the yield was 16%. 1 H-NMR (400MHz, CD3OD): δ = 8.12 (s, 1H), 7.61-7.55 (m, 4H), 7.44 (m, 2H), 7.23 (d, J = 6.5Hz, 1H), 6 .87(s,2H),3.60(m,8H),3.24(m,6H),3.01(m,6H),1.21(t,J=6.8Hz,6H),0.86(t,J=6.7Hz,6H).
[0225] Synthesis of Molecular Rotor 25: Compound 77 (45 mg, 0.072 mmol) was dissolved in 20 mL of DCM, and TMS-Cl (16.5 mg, 0.15 mmol) and KNO (15.3 mg, 0.15 mmol) were added, respectively. The reaction system was stirred at 30°C. After completion of the reaction, the mixture was cooled to room temperature and filtered to remove the residue. The filtrate was extracted with water, and the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The product was purified by column chromatography to obtain the product (45 mg, 90% yield). 1H-NMR (400MHz, CD3OD): δ = 8.23 (s, 1H), 7.60-7.52 (m, 4H), 7.45 (m, 2H), 7.19 (d, J = 6.6Hz, 1H), 6 .85(s,2H),3.62(m,8H),3.26(m,6H),3.20(m,6H),1.21(t,J=6.9Hz,6H),0.86(t,J=6.2Hz,6H).
[0226] Example 26
[0227] Synthesis of compound 80: referring to the synthesis method of molecular rotor 1, the yield was 29%. 1 H-NMR (400MHz, CD3OD): δ = 8.01 (d, J = 7.3Hz, 1H), 7.79-7.61 (m, 2H), 6.97 (d, J = 1.6Hz, 2H), 6.74-6.59 (m, 4 H), 4.32 (t, J = 7.3Hz, 4H), 3.44 (t, J = 5.3Hz, 4H), 2.42 (m, J = 6.9Hz, 8H), 2.36 (s, 6H), 0.73 (t, J = 5.5Hz, 6H).
[0228] Synthesis of molecular rotor 26: The synthesis was carried out according to the reference J.Am.Chem.Soc.2019, 141, 14491-14495, with a yield of 62%. 1 H-NMR (400MHz, CD3OD): δ=8.00(d,J=7.6Hz,1H),7.79(t,J=7.4Hz,1H),7.72(t,J=7.5Hz,1H),7.19(d,J=7.6Hz,1H ),6.87(s,2H),6.80(d,J=8.8Hz,2H),6.62(d,J=8.8Hz,1H),3.61(s,8H),3.53(s,8H),3.18(s,12H),0.73(s,6H).
[0229] Example 27
[0230] Synthesis of compound 82: The synthesis was carried out according to Chem. Commun., 2020, 56, 715-718, with a yield of 74%. 1 H-NMR (400MHz, CDCl3): δ = 8.26 (d, J = 7.8Hz, 2H), 6.95 (s, 2H), 6.91 (d, J = 7.8Hz, 2H), 3.80 (s, 8H), 2.76 (s, 8H), 1.69 (s, 6H).
[0231] Synthesis of compound 83: referring to the synthesis method of molecular rotor 1, the yield was 67%. 1 H-NMR (400MHz, CD3OD): δ = 7.30 (d, J = 1.8Hz, 1H), 7.27 (d, J = 7.8Hz, 2H), 7.05 (d, J = 9.0Hz, 2 H), 6.89 (dd, J=1.8, 7.8Hz, 2H), 4.10 (t, J=4.8Hz, 8H), 2.79 (t, J=4.8Hz, 8H), 1.77 (s, 6H).
[0232] Synthesis of Molecular Rotor 27: Compound 83 (61.3 mg, 0.1 mmol) was dissolved in 20 mL of DCM and added dropwise at 0°C to 3-chloroperoxybenzoic acid (138 mg, 0.81 mmol) in 10 mL of DCM. The reaction system was stirred at 0°C for 2 hours, then cooled to room temperature and stirred for another 4 hours. After completion of the reaction, the reaction solution was washed sequentially with NaHSO₃ and HClO₄ solutions. The organic phase was collected, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography to obtain 20 mg (30% yield). 1 H-NMR (400MHz, CD3OD): δ = 7.41 (d, J = 2.4Hz, 1H), 7.30 (d, J = 7.8Hz, 2H), 7.18 (d, J = 9.6Hz, 2 H),7.02-7.00(dd,J=2.4Hz,2H),4.23(t,J=4.8Hz,8H),3.23(t,J=4.8Hz,8H),1.81(s,6H).
[0233] Example 28
[0234] Synthesis of compound 84: refer to the synthesis method of compound 40, with a yield of 90%. 1 H-NMR (400MHz, DMSO-d6): δ = 11.94 (s, 1H), 7.90 (d, J = 7.6Hz, 1H), 7.09 (d, J = 7.4Hz, 1H), 6.48 (d, J = 9.6Hz, 2H).
[0235] Synthesis of compound 85: The compound was synthesized according to the literature Res Chem Intermed (2013) 39: 4121-4125, with a yield of 96%. 1H-NMR (400MHz, DMSO-d6): δ = 12.46 (s, 1H), 11.94 (s, 1H), 7.90 (d, J = 7.6Hz, 1H), 7.11 (d, J = 7.4Hz, 1H), 6.45 (d, J = 9.6Hz, 2H).
[0236] Synthesis of compound 86: refer to the synthesis method of compound 9, with a yield of 88%. 1 H-NMR (400MHz, DMSO-d6): δ = 12.25 (s, 1H), 11.83 (s, 1H), 7.01 (d, J = 7.4Hz, 1H), 6.51 (d, J = 9.4Hz, 2H).
[0237] Synthesis of molecular rotor 28: Refer to the synthesis method of molecular rotor 1, with a yield of 68%. 1 H-NMR (400MHz, CD3OD): δ = 12.02 (s, 1H), 11.71 (s, 1H), 7.85 (d, J = 7.4Hz, 2H), 7.54 (dd, J = 7.6, 2.2Hz, 2H),7.06(d,J=2.8Hz,2H),6.62(d,J=9.4Hz,2H),6.53(dd,J=9.2Hz,1H),3.06(s,12H),0.68(s,6H).
[0238] Example 29
[0239] Synthesis of compound 87: The compound was synthesized according to ACS Appl. Energy Mater. 2019, 2, 5600-5612, with a yield of 75%. 1 H-NMR (400MHz, CDCl3): δ = 7.32 (d, J = 4.8Hz, 2H), 7.20 (d, J = 4.8Hz, 2H), 0.55 (s, 6H).
[0240] Synthesis of compound 88: The compound was synthesized according to ACS Appl. Energy Mater. 2019, 2, 5600-5612, with a yield of 69%. 1 H-NMR (400MHz, CDCl3): δ = 9.88 (s, 1H), 7.74 (s, 1H), 7.42 (d, J = 4.8Hz, 1H), 7.15 (d, J = 4.8Hz, 1H), 0.47 (s, 6H).
[0241] Synthesis of compound 89: refer to the synthesis method of compound 9, with a yield of 93%. 1H-NMR (400MHz, CDCl3): δ = 9.86 (s, 1H), 7.73 (s, 1H), 7.11 (s, 1H), 0.46 (s, 6H).
[0242] Synthesis of compound 90: The compound was synthesized according to Nat Methods 17, 815-821 (2020), with a yield of 43%. 1 H-NMR (400MHz, CD3OD): δ=7.69-7.59(m,2H),7.33(d,J=9.2Hz,2H),7.21-7.16(m,2H),4.27-4.13(m,8H),3.94(m,4H),1.51(s,6H).
[0243] Synthesis of molecular rotor 29: Refer to the synthesis method of molecular rotor 1, with a yield of 76%. 1 H-NMR (400MHz, CD3OD): δ = 10.41 (d, J = 8.1Hz, 1H), 8.37 (dd, J = 8.2, 1.6Hz, 1H), 7.89 (d, J = 1.6Hz, 1H), 7.18 (d, J=9.2Hz,2H),6.70(dd,J=9.2,2.0Hz,2H),6.45(d,J=2.0Hz,2H),4.30-4.21(m,8H),4.08(m,4H),1.54(s,6H).
[0244] Example 30
[0245] Synthesis of compound 91: referring to the synthesis method of molecular rotor 1, the yield was 66%. 1 H-NMR (400MHz, CD3OD): δ = 7.75-7.67 (m, 2H), 7.53-7.46 (m, 5H), 7.39 (s, 1H), 6.78 (dd, J = 13.8, 2.6Hz, 2H), 6.7 7(d,J=8.8,5.9Hz,2H),6.45(dd,J=8.8,2.5Hz,2H),3.71(t,J=7.4Hz,8H),2.65(t,J=7.3Hz,8H),1.46(s,9H).
[0246] Synthesis of Molecular Rotor 30: Compound 91 (50 mg, 0.078 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and sulfamethoxazole (16 mg, 0.085 mmol), condensing agent PyBop (61 mg, 0.12 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The combined organic phases were dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was then purified by column chromatography to obtain the product (48 mg, 82% yield). 1 H-NMR (400MHz, CD3OD): δ=7.77(m,2H),7.71(m,5H),7.44(m,5H),7.24(m,2H),6.86(m,2 H), 6.20 (m, 1H), 5.89 (m, 1H), 4.35 (s, 2H), 3.75 (t, J = 7.4Hz, 8H), 2.56 (t, J = 7.4Hz, 8H).
[0247] Example 31
[0248] Synthesis of compound 92: refer to the synthesis method of compound 40, with a yield of 92%. 1 H-NMR (400MHz, CDCl3): δ=7.72-7.65(m,2H),7.47-7.41(m,1H),7.36-7.33(m,1H),6.84(m,1H),2.64(s,3H).
[0249] Synthesis of compound 93: refer to the synthesis method of compound 2, with a yield of 65%. 1 H-NMR (400MHz, CDCl3): δ = 7.69 (m, 2H), 7.44 (m, 1H), 7.40 (m, 1H), 6.84 (m, 1H), 2.64 (s, 3H), 1.76 (m, 9H).
[0250] Synthesis of compound 94: The compound 94 was synthesized according to J.Am.Chem.Soc.2015, 137, 4759-4765, with a yield of 74%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.37 (d, J = 8.7Hz, 2H), 7.66-7.63 (m, 4H), 7.49 (s, 2H), 7.45 (dd, J = 2 .4,8.7Hz,2H),7.29(d,J=8.7Hz,2H),4.15(t,J=9.0Hz,4H),3.22(t,J=9.0Hz,4H),0.54(s,6H).
[0251] Synthesis of compound 95: referring to the synthesis method of molecular rotor 1, the yield was 76%. 1 H-NMR (400MHz, DMSO-d6): δ = 7.82 (d, J = 2.10Hz, 2H), 7.59-7.45 (m, 11H), 7.27 (d, J = 7.50Hz, 1H), 7.15 (d, J = 9. 10Hz,2H),4.41(t,J=7.50Hz,4H),3.25(t,J=7.50Hz,4H),2.05(s,3H),1.45(s,9H),0.70(s,3H),0.67(s,3H).
[0252] Synthesis of Molecular Rotor 31: Compound 95 (70 mg, 0.078 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and bromo-2,2'-oxybis(ethylamine) (9 mg, 0.087 mmol), condensing agent PyBop (61 mg, 0.12 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography (66 mg, 85% yield). 1 H-NMR (400MHz, DMSO-d6): δ = 7.84-7.75 (m, 6H), 7.62 (d, J = 8.7Hz, 2H), 7.43-7.27 (m, 7H), 6.68 (m, 2H), 4. 43(t,J=6.6Hz,4H),4.13(t,J=6.1Hz,4H),3.87(t,J=5.6Hz,4H),3.33(m,4H),2.05(s,3H),0.70(s,6H).
[0253] Example 32
[0254] Synthesis of compound 96: The compound was synthesized according to Nat Methods 17, 815-821 (2020), with a yield of 43%. 1H-NMR (400MHz, CD3OD): δ = 7.27 (d, J = 9.2Hz, 2H), 6.78 (dd, J = 9.2, 2.0Hz, 2H), 6.61 (d, J = 2.0Hz, 2H), 5.55 ( dd,J=6.0,3.1Hz,2H),4.61-4.48(m,4H),4.39-4.23(m,4H),4.65-4.56(m,8H),4.15(s,2H),1.70(s,6H).
[0255] Synthesis of compound 97: referring to the synthesis method of molecular rotor 1, the yield was 69%. 1 H-NMR (400MHz, CD3OD): δ = 8.19-8.13 (m, 1H), 7.69 (td, J = 7.6, 1.5Hz, 1H), 7.64 (td, J=7.4,1.6Hz,1H),7.49(d,J=9.2Hz,2H),7.23-7.18(m,1H),6.85(dd,J=9.2,2.0Hz, 2H),1.55(s,9H),1.70(s,6H).
[0256] Synthesis of Molecular Rotor 32: Compound 97 (75 mg, 0.14 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and diethylene glycol (16 mg, 0.15 mmol), DMAP (26 mg, 0.21 mmol), and EDC (40 mg, 0.21 mmol) were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography (63 mg, 79% yield). 1 H-NMR (400MHz, CD3OD): δ = 7.43 (d, J = 9.1Hz, 2H), 6.76 (dd, J = 9.2, 2.2Hz, 2H), 6.62 (d, J = 2.2Hz, 2H) ,5.59(dd,J=6.0,3.0Hz,2H),4.70-4.56(m,4H),4.47-4.34(m,4H),3.69-3.57(m,8H),1.70(s,6H).
[0257] Example 33
[0258] Synthesis of compound 98: refer to the synthesis method of compound 9, with a yield of 92%. 1H-NMR (400MHz, CDCl3): δ = 8.29 (d, J = 8.7Hz, 1H), 7.61 (d, J = 1.9Hz, 1H), 7.43 (dd, J = 8.7, 1.9Hz, 1H), 7.16 (s, 1H), 2.57 (s, 3H).
[0259] Synthesis of compound 99: refer to the synthesis method of compound 2, with a yield of 95%. 1 H-NMR (400MHz, CDCl3): δ = 8.43 (d, J = 7.2Hz, 1H), 7.52-7.48 (m, 1H), 7.37 (t d,J=7.3,1.5Hz,1H),7.30(td,J=7.3,1.5Hz,1H),2.62(s,3H),1.62(s,9H).
[0260] Synthesis of compound 100: The compound was synthesized according to Nat Methods 17, 815-821 (2020), with a yield of 23%. 1 H-NMR (400MHz, CD3OD): δ = 7.40 (d, J = 9.3Hz, 2H), 6.83 (d, J = 2.3Hz, 2H), 6.68 (dd, J = 9.4, 2.3Hz, 2H), 4.35-4.22 (m, 8H).
[0261] Synthesis of compound 101: referring to the synthesis method of molecular rotor 1, the yield was 73%. 1 H-NMR (400MHz, CD3OD): δ=7.37 (dd, J=9.1, 0.5Hz, 2H), 6.72 (dd, J=9.2, 2.2Hz, 2H), 6.58 (d, J=2.2H z,3H),6.26(dd,J=6.0,3.0Hz,2H),4.66-4.53(m,4H),4.44-4.30(m,4H),2.37(s,3H),1.62(s,9H).
[0262] Synthesis of Molecular Rotor 33: Compound 101 (60 mg, 0.098 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and ethylene glycol (6.8 mg, 0.11 mmol), DMAP (18 mg, 0.15 mmol), and EDC (28 mg, 0.15 mmol) were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography (48 mg, 82% yield). 1H-NMR (400MHz, CD3OD): δ=6.75 (d, J=8.6Hz, 2H), 6.26 (d, J=2.3Hz, 3H), 6.22 (dd, J=8.6, 2.3Hz, 2H),6.05(dd,J=6.1,3.5Hz,2H),4.31-4.19(m,4H),4.12-4.00(m,4H),3.84(t,J=8.3Hz,2H),3.72(t,J=8.1Hz,2H),2.37(s,3H).
[0263] Example 34
[0264] Synthesis of compound 102: The compound 102 was synthesized according to Org. Lett. 2009, 11, 14, 3144-3147. 1 H-NMR (400MHz, CDCl3): δ=7.57 (d, J=2.1Hz, 1H), 7.13 (d, J=0.5Hz, 1H), 6.66 (dd, J=2.1, 0.5Hz, 1H).
[0265] Synthesis of compound 103: Synthesized according to Angew.Chem.Int.Ed.2018,57,6910. 1 H-NMR (400MHz, CDCl3): δ = 7.19 (d, J = 5.3Hz, 1H), 7.03 (dd, J = 5.3, 0.5Hz, 1H), 6.69 (d, J = 0.5Hz, 1H).
[0266] Synthesis of compound 104: refer to the synthesis method of compound 9, with a yield of 60%. 1 H-NMR (400MHz, CDCl3): δ=7.12 (d, J=5.1Hz, 1H), 6.96 (dd, J=5.1, 0.4Hz, 1H).
[0267] Synthesis of compound 105: refer to the synthesis method of compound 2, with a yield of 56%. 1 H-NMR (400MHz, CDCl3): δ = 7.16 (d, J = 5.3Hz, 1H), 6.91 (dd, J = 5.2, 0.4Hz, 1H), 1.42 (s, 9H).
[0268] Synthesis of compound 106: referring to the synthesis method of molecular rotor 1, the yield was 65%. 1H-NMR (400MHz, CD3OD): δ = 7.68 (d, J = 6.9Hz, 1H), 7.29 (m, 2H), 7.10 (d, J = 7.5Hz, 1H), 7.02 (d, J = 6.6Hz, 1H), 6.78(d,J=8.3Hz,1H),6.68(d,J=2.5Hz,1H),6.43(d,J=2.6Hz,1H),3.09(s,12H),1.56(s,9H),1.38(s,6H).
[0269] Synthesis of Molecular Rotor 34: Compound 106 (85 mg, 0.17 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and N-(2-aminoethyl)morpholine (24 mg, 0.19 mmol), the condensing agent PyBop (131 mg, 0.25 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography (85 mg, 39% yield). 1 H-NMR (400MHz, CD3OD): δ = 7.16-7.10 (m, 3H), 6.88 (t, J = 7.5Hz, 1H), 6.81 (t, J = 7.5Hz, 1H), 6.47 (d, J = 7.5Hz, 2H), 6.08 (d, J = 9. 5Hz,1H),3.70(q,J=7.2Hz,8H),3.52(t,J=7.0Hz,2H),3.36(t,J=5.6Hz,2H),1.54(t,J=7.2Hz,12H),0.62(s,3H),0.61(s,3H).
[0270] Example 35
[0271] Synthesis of compound 107: Synthesized according to Angew. Chem. Int. Ed., 2017, 56, 4197-4200, with a yield of 12%. 1 H-NMR (400MHz, CD3OD): δ=7.39 (d, J=2.5Hz, 2H), 6.74 (d, J=8.7Hz, 2H), 6.40 (dd, J=8. 7,2.5Hz,2H),4.01(d,J=7.4Hz,2H),3.42(m,4H),2.36(s,6H),1.46(t,J=7.3Hz,6H).
[0272] Synthesis of compound 108: referring to the synthesis method of molecular rotor 1, the yield was 66%. 1 H-NMR (400MHz, CD3OD): δ = 8.77 (t, J = 5.2Hz, 1H), 8.39 (d, J = 8.3Hz, 1H), 8.19 (dd, J = 8.2, 1.8Hz, 1H), 7.75 (d, J = 1.8Hz, 1H), 7.19 ( d,J=9.2Hz,2H),6.69(dd,J=9.3,2.0Hz,2H),4.47(d,J=2.0Hz,2H),3.54(m,4H),2.36(s,6H),1.76(s,9H),1.56(t,J=7.3Hz,6H).
[0273] Synthesis of Molecular Rotor 35: Compound 108 (75 mg, 0.15 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and (2-aminoethyl)triphenylphosphonium bromide (65 mg, 0.17 mmol), the condensing agent PyBop (120 mg, 0.23 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography to obtain 96 mg (87% yield). 1 H-NMR (400MHz, CD3OD): δ = 7.44 (t, J = 5.2Hz, 1H), 7.36 (m, 16H), 7.06 (d, J = 8.3Hz, 1H), 6.74 (dd, J = 8.2, 1.8Hz, 1H), 6.09 (d, J = 1.8Hz, 1H), 6.5 0(d,J=9.2Hz,2H),6.20(dd,J=9.3,2.0Hz,1H),4.07(d,J=2.0Hz,2H),3.45(m,4H),3.03(t,J=6.2Hz,2H),2.36(s,6H),1.56(t,J=7.3Hz,6H).
[0274] Example 36
[0275] Synthesis of compound 109: referring to the synthesis method of compound 40, the yield was 76%. 1 H-NMR (400MHz, CDCl3): δ = 7.49 (s, 1H), 7.02 (d, J = 1.5Hz, 1H), 6.24 (m, 2H).
[0276] Synthesis of compound 110: refer to the synthesis method of compound 2, with a yield of 82%.1 H-NMR (400 MHz, CDCl3): δ = 7.64 (dd, J = 8.2Hz, 1H), 6.94 (dt, J = 8.0, 1.6Hz, 1H), 6.85 (dt, J = 7.1Hz, 1H), 6.78 (m, 1H), 1.64 (s, 9H).
[0277] Synthesis of compound 111: synthesized according to Chem. Sci., 2019, 10, 9028-9037, with a yield of 20%. 1 H-NMR (400MHz, CDCl3): δ = 8.07 (s, 2H), 3.29-3.27 (m, 8H), 2.91-2.80 (m, 8H), 2.03-1.96 (m, 8H), 0.59 (s, 6H).
[0278] Synthesis of compound 112: referring to the synthesis method of molecular rotor 1, the yield was 66%. 1 H-NMR (400MHz, CDCl3): δ = 7.81 (d, J = 8.0Hz, 2H), 7.38 (d, J = 8Hz, 2H), 6.93 (s, 2H), 4.72 (s, 2H), 3.77-3.75 (m,4H),3.64(m,4H),3.39(s,4H),2.95-2.90(m,4H),2.75(m,4H),1.34(s,9H),0.68(s,3H),0.61(s,3H).
[0279] Synthesis of molecular rotor 36: The synthesis was carried out according to the literature Nat Commun 12, 4065 (2021), with a yield of 70%. 1 H-NMR (400MHz, CDCl3): δ = 7.76 (t, J = 5.3Hz, 1H), 7.43 (d, J = 8.2Hz, 1H), 7.22 (dd, J = 8.2, 1.8Hz, 1H), 6.79 (d, J = 1.8Hz, 1H), 6.36 ( d,J=9.2Hz,2H),3.35-3.30(m,8H),3.18-3.12(m,2H),2.85-2.82(m,8H),2.15-2.08(m,8H),1.55(d,J=0.7Hz,6H),0.56(s,6H).
[0280] Example 37
[0281] Synthesis of compound 114: referring to the synthesis method of molecular rotor 1, the yield was 14%. 1H-NMR (400MHz, CD3OD): δ=7.65-7.37(m,2H),7.18(t,J=7.8Hz,1H),7.04(td,J=10.3,6.8Hz,3H),6.83(dd,J=9 .7,2.8Hz,2H),4.09(dp,J=9.6,7.2Hz,2H),3.38(s,12H),2.06(d,J=21.9Hz,3H),1.24(dt,J=18.1,7.0Hz,3H).
[0282] Synthesis of molecular rotor 37: refer to the synthesis method of molecular rotor 13, with a yield of 14%. 1 H-NMR (400MHz, CD3OD): δ=7.46-7.29(m,3H),7.08(d,J=7.5Hz,1H),6.43(d,J=6.1Hz,3H),3.12(s,12H),2.40(s,3H).
[0283] Example 38
[0284] Synthesis of compound 115: refer to the synthesis method of compound 9, with a yield of 90%. 1 H-NMR (400MHz, DMSO-d6): δ = 12.90 (s, 1H), 8.13 (d, J = 1.9Hz, 2H), 7.73 (s, 1H), 7.16 (s, 1H).
[0285] Synthesis of compound 116: refer to the synthesis method of compound 2, with a yield of 96%. 1 H-NMR (400 MHz, DMSO-d6): δ = 8.15 (d, J = 1.9 Hz, 2H), 7.65 (s, 1H), 7.21 (s, 1H), 1.65 (s, 9H).
[0286] Synthesis of compound 117: The compound 117 was synthesized with reference to J. Med. Chem. 2009, 52, 10, 3328-3341, with a yield of 40%. 1 H-NMR (400MHz, CDCl3): δ = 7.75 (dd, J = 2.5, 9.0Hz, 2H), 6.54 (dd, J = 2.5, 8.5Hz, 2H), 6.49 (d, J = 2.5Hz, 2H), 5.65 (s, 4H).
[0287] Synthesis of compound 118: referring to the synthesis method of molecular rotor 1, the yield was 74%. 1H-NMR (400MHz, CDCl3): δ = 9.11 (s, 2H), 8.11 (d, J = 8.5Hz, 1H), 7.74 (m, 2H), 7.61 (m, 1H), 7.54 (m,1H),7.47(m,1H),7.38(d,J=9.9Hz,2H),7.24(d,J=8.5Hz,2H),5.47(s,2H),1.56(s,9H).
[0288] Synthesis of Molecular Rotor 38: Compound 118 (69 mg, 0.16 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and ethylamine (8 mg, 0.17 mmol), the condensing agent PyBop (122 mg, 0.23 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the reaction mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The intermediate was then purified by column chromatography. The intermediate (50 mg, 0.12 mmol) and 1,3-propane sultone (30 mg, 0.24 mmol) were placed in a 50 mL round-bottom flask and dissolved in 20 mL of acetonitrile. The reaction system was heated to 100°C in an oil bath under nitrogen and allowed to react for 20 hours. After the reaction is completed, the reaction system is cooled to room temperature, and the organic solvent in the system is removed by vacuum distillation. The residue is extracted with 100 mL of EA and water, and the organic phases are combined, dried over anhydrous sodium sulfate, and the solvent is removed by vacuum distillation. The product is purified by column chromatography (13 mg, yield 20%). 1 H-NMR (400MHz, CD3OD): δ = 9.16 (s, 2H), 7.76 (d, J = 9.5Hz, 2H), 7.26 (d, J = 2.5Hz, 2H), 7.21 (d, J = 3.5Hz, 1H), 7. 07(d,J=3.5Hz,2H),6.95(dd,J=2.5,9.8Hz,2H),4.99(s,2H),4.02(s,2H),3.28(m,6H),1.81(t,J=2.5Hz,3H).
[0289] Example 39
[0290] Synthesis of compound 119: The compound 119 was synthesized according to Dyes and Pigments 99 (2013) 1091-1100, with a yield of 39%. 1H-NMR (400MHz, CDCl3): δ = 9.83 (s, 1H), 7.61 (s, 1H), 7.07 (d, 1H), 1.47 (s, 6H).
[0291] Synthesis of compound 120: referring to the synthesis method of molecular rotor 1, the yield was 74%. 1 H-NMR(400 MHz, CD3OD): δ = 9.84 (s, 1H), 7.43-7.26 (m, 3H), 7.22 (d, J = 7.5Hz, 1H), 7.08 (d, J = 2.8Hz, 2H), 7.02 (s, 1H), 6.99 (s, 1H), 3.20 (s, 12H), 1.49 (s, 6H).
[0292] Synthesis of compound 121: The compound 121 was synthesized according to the reference J.Am.Chem.Soc.2021,143,912-924, with a yield of 97%. 1 H-NMR (400MHz, CDCl3): δ = 7.37 (s, 1H), 3.58-3.45 (m, 2H), 3.21-3.25 (m, 2H), 1.61-1.48 (m, 2H), 1.33-1.17 (m, 20H), 0.87 (t, J = 7.0Hz, 3H).
[0293] Synthesis of Molecular Rotor 39: Compound 120 was first oxidized to the aldehyde group according to Catalysis Letters volume 151, pages 36-44 (2021) to obtain an intermediate. The intermediate (70 mg, 0.12 mmol) was then dissolved in 10 mL of anhydrous DMF. HATU (50 mg, 0.13 mmol), HOBt (9 mg, 0.06 mmol), and DIPEA (64 mg, 0.5 mmol) were added and stirred under nitrogen for 5 minutes. Compound 121 (33 mg, 0.13 mmol) and DIPEA (32 mg, 0.25 mmol) were dissolved in 1 mL of anhydrous DCM and added to the reaction mixture. The mixture was stirred at room temperature under nitrogen for 24 hours. After completion of the reaction, the organic solvent was removed by distillation under reduced pressure, and the crude product was purified by column chromatography to obtain the product (56 mg, 44% yield). 1H-NMR (400MHz, CDCl3): δ = 8.63 (d, J = 7.8Hz, 2H), 8.25 (d, J = 7.8Hz, 1H), 7.71 (td, J =7.5,1.0Hz,1H),7.63(td,J=7.5,1.0Hz,1H),7.56(d,J=9.0Hz,2H),6.82(s,1H),6 .69(dd,J=9.0,2.5Hz,2H),3.35-3.52(m,8H),2.31(t,J=7.3Hz,2H),2.18(t,J=7.7 Hz,2H),1.93-2.03(m,2H),1.47(s,6H),1.16-1.32(m,23H),0.87(t,J=6.9Hz,3H).
[0294] Example 40
[0295] Synthesis of compound 122: refer to the synthesis method of compound 40, with a yield of 92%. 1 H-NMR (400MHz, CDCl3): δ = 8.14 (s, 1H), 8.07 (s, 1H), 7.99 (m, 1H), 7.80 (d, J = 1.6Hz, 1H), 7.46 (m, 2H), 7.38 (m, 2H), 1.39 (s, 9H).
[0296] Synthesis of compound 123: refer to the synthesis method of compound 9, with a yield of 86%. 1 H-NMR (400MHz, CDCl3): δ = 8.12 (s, 1H), 7.84 (d, J = 8.4Hz, 1H), 7.79 (d, J = 1.6Hz, 1H), 7.62 (m, 2H), 7.48 (t, J = 7.2Hz, 2H), 1.37 (s, 9H).
[0297] Synthesis of compound 124: referring to the synthesis method of molecular rotor 1, the yield was 74%. 1 H-NMR (400MHz, CD3OD): δ = 8.12 (s, 2H), 7.75-7.70 (m, 4H), 7.60 (s, 1H), 7.16 (s, 1H), 6.78 (t, J = 7.2Hz, 2H), 6.44 (m, 3H), 3.02 (s, 12H), 1.37 (s, 9H), 0.65 (s, 6H).
[0298] Synthesis of compound 125: The compound 125 was synthesized according to the reference J.Am.Chem.Soc.2021,143,912-924, with a yield of 97%. 1H-NMR (400MHz, CDCl3): δ = 7.43 (s, 1H), 7.02 (s, 1H), 3.78 (t, J = 5.3Hz, 2H), 3.71-3.58 (m, 44H), 3.15 (sxt, J = 5.4Hz, 2H).
[0299] Synthesis of Molecular Rotor 40: Compound 124 (93 mg, 0.15 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and compound 125 (102 mg, 0.17 mmol), the condensing agent PyBop (117 mg, 0.23 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography (162 mg, 61% yield). 1 H-NMR (400MHz, CDCl3): δ = 8.62 (d, J = 7.5Hz, 1H), 8.25 (d, J = 7.5Hz, 1H), 7.70 (td, J = 7.53, 1.2Hz,2H),7.62(td,J=7.53,1.2Hz,1H),7.57(d,J=9.3Hz,1H),7.40-7.32(m,3H),6.70( dd,J=9.0,2.5Hz,1H),6.56(t,J=4.5Hz,1H),6.49(d,J=2.5Hz,1H),6.35(s,1H),3.69-3. 55(m,44H),3.50-3.39(m,8H),3.02(s,12H),2.30(t,J=7.0Hz,2H), 0.67(t,J=7.0Hz,6H).
[0300] Example 41
[0301] Synthesis of compound 126: The compound 126 was synthesized according to J.Am.Chem.Soc.2000, 122, 1820-1821, with a yield of 64%. 1 H-NMR (400MHz, DMSO-d6): δ = 10.32 (s, 1H), 7.64 (d, J = 4.0Hz, 1H), 7.36-7.22 (m, 3H).
[0302] Synthesis of compound 127: refer to the synthesis method of compound 2, with a yield of 62%. 1H-NMR (400MHz, CDCl3): δ=7.87 (d, J=3.9Hz, 1H), 7.15 (d, J=3.9Hz, 1H), 7.12 (d, J=3.9Hz, 1H), 7.05 (d, J=4.0Hz, 1H), 1.45 (s, 9H).
[0303] Synthesis of compound 128: referring to the synthesis method of molecular rotor 1, the yield was 70%. 1 H-NMR (400MHz, CD3OD): δ = 7.68 (d, J = 3.9Hz, 2H), 7.31 (dd, J = 6.2, 3.3Hz, 2H), 7.04 (d, J = 8.9Hz, 2H), 6.83 (dd, J=8.9,2.8Hz,1H),6.77(dd,J=9.6,2.8Hz,2H),6.40(d,J=2.8Hz,1H),3.33(s,12H),0.60(s,3H),0.56(s,3H).
[0304] Synthesis of Molecular Rotor 41: Compound 128 (40 mg, 0.08 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and 6-[[4-(aminomethyl)phenyl]methoxy]-7H-purin-2-amine (24 mg, 0.089 mmol), the condensing agent PyBop (63 mg, 0.12 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography to obtain the product (38 mg, 68% yield). 1 H-NMR (400MHz, CD3OD): δ = 8.33 (s, 1H), 8.25 (m, 3H), 7.95 (d, J = 7.1Hz, 1H), 7.56 (d, J = 8.0Hz, 2H), 7.46 (d, J = 8.0, 2H), 7.37 (d, J = 2.6Hz, 1H), 7.27 (d,J=7.9Hz,1H),7.04(d,J=9.6Hz,2H),6.75(dd,J=9.6,2.6Hz,2H),5.66(s,2H),4.66(s,2H),3.35(s,12H),0.61(s,3H),0.60(s,3H).
[0305] Example 42
[0306] Synthesis of compound 129: referring to the synthesis method of molecular rotor 1, the yield was 56%. 1H-NMR (400MHz, CD3OD): δ = 8.46 (s, 2H), 8.23 (d, J = 8.0Hz, 1H), 7.88 (t, J = 7.5Hz, 1H), 7.81 (t, J = 7.5Hz, 1H), 7.47 (d, J = 7 .5Hz,1H),7.08(d,J=9.5Hz,2H),7.01(d,J=9.5Hz,2H),3.64(q,J=6.5Hz,12H),1.51(s,9H),0.65(s,3H),0.63(s,3H).
[0307] Synthesis of Molecular Rotor 42: Compound 129 (40 mg, 0.08 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and 2-(2-(6-chlorohexyloxy)ethoxy)ethanamine (23 mg, 0.089 mmol), condensing agent PyBop (63 mg, 0.12 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography (18 mg, 34% yield). 1 H-NMR (400MHz, CD3OD): δ = 8.22 (s, 1H), 7.92 (d, J = 7.8Hz, 2H), 7.37 (d, J = 2.6 Hz,2H),7.26(d,J=7.8Hz,2H),7.05(d,J=9.6Hz,2H),6.76(dd,J=9.6,2.6Hz, 2H),4.37(s,2H),3.71-3.61(m,8H),3.53-3.49(m,4H),3.35(s,12H),1.77- 1.70(m,2H),1.63-1.56(m,2H),1.48-1.37(m,2H),0.62(s,3H),0.61(s,3H).
[0308] Example 43
[0309] Synthesis of compound 130: Synthesized according to Science 370, 424 (2020), with a yield of 80%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.46-8.30 (s, 2H), 7.85-7.82 (m, 2H), 4.62 (m, 4H).
[0310] Synthesis of compound 131: refer to the synthesis method of compound 40, with a yield of 92%. 1H-NMR (400MHz, DMSO-d6): δ = 8.38 (s, 1H), 8.25 (s, J = 15.0Hz, 1H), 8.00-7.91 (m, 2H), 7.73-7.69 (m, 1H), 3.72 (s, 2H).
[0311] Synthesis of molecular rotor 43: refer to the synthesis method of molecular rotor 1, with a yield of 70%. 1 H-NMR (400MHz, CD3OD): δ = 7.40 (m, 4H), 7.22 (s, 2H), 7.08 (d, J = 7.3Hz, 1H), 6.68 (s, 2H), 4.8 (s, 2H), 3.60 ( t,J=5.1Hz,4H),3.33(s,6H),2.48(t,J=5.9Hz,4H),1.91(dt,J=5.9,5.1Hz,4H),0.57(s,3H),0.55(s,3H).
[0312] Example 44
[0313] Synthesis of compound 132: referring to the synthesis method of molecular rotor 1, the yield was 56%. 1 H-NMR (400MHz, CD3OD): δ = 8.38 (s, 1H), 8.27 (d, J = 7.8Hz, 1H), 7.30 (d, J = 8.0Hz, 1H), 6.73 (d, J = 12 .3Hz,4H),6.57(d,J=8.7Hz,1H),3.23(s,8H),2.47(s,8H),2.24(s,6H),1.42(s,9H),0.66(s,6H).
[0314] Synthesis of molecular rotor 44: referring to the synthesis method of molecular rotor 20, the yield was 86%. 1 H-NMR (400MHz, CD3OD): δ = 8.41 (s, 1H), 8.30 (d, J = 8.0Hz, 1H), 7.23 (d, J = 8.0Hz, 1H), 6.89 (s, 2H), 6.82 (d, J = 9.0Hz, 2H), 6.69 ( d,J=8.8Hz,2H),3.72(t,J=8.3Hz,2H),3.67(t,J=8.3Hz,2H),3.63(s,8H),3.54(s,8H),3.20(s,6H),3.04(s,3H),0.66(s,6H).
[0315] Example 45
[0316] Synthesis of compound 133: The compound 133 was synthesized according to Chemistry of Materials (2007), 19(16), 4007-4015, with a yield of 50%. 1 H-NMR (400MHz, CDCl3): δ = 7.37 (d, J = 5.1Hz, 1H), 7.22 (s, 1H).
[0317] Synthesis of compound 134: The aldehyde group was oxidized according to Catalysis Letters volume 151, pages 36-44 (2021) to obtain the product with a yield of 83%. 1 H-NMR (400MHz, CDCl3): δ = 7.35 (d, J = 5.3Hz, 1H), 7.24 (s, 1H).
[0318] Synthesis of compound 135: refer to the synthesis method of compound 2, with a yield of 83%. 1 H-NMR (400MHz, CDCl3): δ = 7.35 (d, J = 5.3Hz, 1H), 7.24 (s, 1H), 1.51 (s, 9H).
[0319] Synthesis of compound 136: referring to the synthesis method of molecular rotor 1, the yield was 56%. 1 H-NMR (400MHz, CD3OD): δ = 8.38 (s, 1H), 8.27 (d, J = 7.8Hz, 1H), 7.30 (d, J = 8.0Hz, 1H), 6.73 (d ,J=12.3Hz,4H),6.57(d,J=8.7Hz,1H),3.23(s,8H),2.47(s,8H),2.24(s,6H),1.51(s,9H).
[0320] Synthesis of compound 137: The compound 137 was synthesized according to J. Am. Chem. Soc. 2011, 133, 15280-15283, with a yield of 80%. 1 H-NMR (400MHz, CDCl3): δ=3.84-3.81(t,2H), 3.87-3.78(t,2H), 3.69-3.68(d,4H), 3.50-3.48(t,2H), 3.27(s,2H).
[0321] Synthesis of Compound 138: Compound 136 (95 mg, 0.14 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and compound 140 (33 mg, 0.16 mmol), condensing agent PyBop (111 mg, 0.21 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product (82 mg, 72% yield) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ=8.17(d,1H),7.79(d,1H),7.16(d,1H),6.69(m,4H),6.56(m,2H), 3.83,(s,2H),3.73(t,2H),3.69(m,6H),3.37(m,2H),3.23(s,8H),2.47(s,8H),2.24(s,6H).
[0322] Synthesis of molecular rotor 45: referring to the synthesis method of molecular rotor 26, the yield was 83%. 1 H-NMR (400MHz, CD3OD): δ = 8.41 (s, 1H), 8.30 (d, J = 8.0Hz, 1H), 7.23 (d, J = 8.0Hz, 1H), 6.89 (s, 2H), 6.82 (d, J = 9. 0Hz, 2H), 6.69 (d, J = 8.8Hz, 2H), 3.73 (t, 2H), 3.69 (m, 6H), 3.63 (s, 8H), 3.54 (s, 8H), 3.37 (m, 2H), 3.20 (s, 12H).
[0323] Example 46
[0324] Synthesis of compound 139: referring to the synthesis method of compound 40, the yield was 86%. 1 H-NMR (400MHz, CDCl3): δ = 7.35 (s, 1H), 7.25 (s, 1H), 7.12-7.01 (m, 2H).
[0325] Synthesis of compound 140: refer to the synthesis method of compound 2, with a yield of 66%. 1 H-NMR (400MHz, CDCl3): δ = 7.34 (s, 1H), 7.29 (s, 1H), 7.22-7.11 (m, 2H), 1.54 (s, 9H).
[0326] Synthesis of compound 141: The compound 141 was synthesized according to Angew.Chem.Int.Ed.2018, 57, 15702-15706 and Chem.Commun., 2016, 52, 12290-12293. 1 H-NMR (400MHz, CDCl3): δ = 8.40 (d, J = 3.7Hz, 1H), 8.37 (d, J = 3.7Hz, 1H), 7.04 (d, J = 2.9Hz, 1H), 6.98 (dd, J = 8.8Hz, 2. 2Hz, 1H), 6.84 (dd, J = 9.5H, 2.9Hz, 1H), 6.78 (d, J = 2.9Hz, 1H), 4.45 (s, 2H), 3.10 (s, 6H), 1.34 (q, J = 6.9, 6.1Hz, 3H).
[0327] Synthesis of compound 142: referring to the synthesis method of molecular rotor 1, the yield was 66%. 1 H-NMR (400MHz, CD3OD): δ = 7.58-7.40 (m, 3H), 7.32 (d, J = 7.4Hz, 1H), 7.26-7.11 (m, 1H), 7.04-6.87 (m,3H),6.80(q,J=8.3Hz,2H),4.10(s,2H),3.21(s,6H),1.56(s,9H),1.34(q,J=6.9,6.1Hz,3H).
[0328] Synthesis of Molecular Rotor 46: Compound 142 (73 mg, 0.12 mmol) was dissolved in 8 mL of anhydrous DCM, followed by the addition of 2 mL of trifluoroacetic acid. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The resulting solid was then dissolved in anhydrous DMF, and diglycolamine (14 mg, 0.13 mmol), the condensing agent PyBop (92 mg, 0.18 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product was purified by column chromatography (55 mg, 72% yield). 1H-NMR (400MHz, CD3OD): δ = 8.63 (dd, J = 8.2, 1.1Hz, 2H), 8.29 (dd, J = 7.8, 1.0Hz, 1H), 7.72 (td, J=8.0,1.8Hz,1H),7.65(td,J=7.8,1.0Hz,1H),7.58(d,J=9.3Hz,1H),7.07(t,J=4.5Hz,1H), 6.69(dd,J=9.3,2.8Hz,1H),6.49(d,J=2.8Hz,1H),6.36(s,1H),5.40(s,1H),4.51(t,J=9.1, 4.1,2.6Hz,2H),3.90(m,6H),3.32(d,J=3.7Hz,2H),3.10(s,6H),1.23(q,J=6.9,6.1Hz,3H).
[0329] Example 47
[0330] Synthesis of molecular rotor 47: Refer to the synthesis method of molecular rotor 1, with a yield of 78%. 1 H-NMR (400MHz, CD3OD): δ = 7.47 (s, 1H), 7.31 (d, J = 8.0Hz, 1H), 7.16-7.12 (m, 2H), 7.03 (s, 1H) ),6.77(s,1H),6.20(s,1H),5.91(s,1H),3.64(q,J=6.5Hz,12H),0.65(s,3H),0.63(s,3H).
[0331] Example 48
[0332] Synthesis of compound 144: referring to the synthesis method of compound 40, the yield was 86%. 1 H-NMR (400MHz, CDCl3): δ=8.07 (d, J=5.3Hz, 2H), 7.60 (t, J=7.6Hz, 3H), 7.10 (s, 1H), 6.54 (s, 1H).
[0333] Synthesis of molecular rotor 48: Refer to the synthesis method of molecular rotor 1, with a yield of 78%. 1H-NMR (400MHz, CD3OD): δ = 8.12 (d, J = 5.2Hz, 2H), 7.58 (t, J = 6.9Hz, 3H), 7.08 (m, 3H), 6.77 (d, J = 7.6Hz ,2H),6.20(d,J=6.5Hz,1H),5.90(t,J=7.8Hz,2H),3.64(q,J=6.5Hz,12H),0.65(s,3H),0.63(s,3H).
[0334] Comparative Example 1
[0335] Synthesis of comparative molecule 1: synthesized according to the literature Analyst, 2020, 145, 7736, with a yield of 12%. 1 H-NMR (400MHz, DMSO-d6): δ = 7.74 (d, J = 8.3Hz, 2H), 7.09 (d, J = 2.9Hz, 2H), 6.99 (d, J = 7. 8Hz, 2H), 6.64 (d, J = 9.3Hz, 2H), 6.40 (dd, J = 9.3, 2.9Hz, 2H), 2.96 (s, 12H), 0.15 (s, 6H).
[0336] Comparative Example 2
[0337] Synthesis of comparative molecule 2: synthesized according to the literature J.Am.Chem.Soc.2019,141,7562-7571, with a yield of 47%. 1 H-NMR (400MHz, CD3OD): δ = 8.88 (d, J = 1.7Hz, 1H), 8.40 (dd, J = 7.9, 1.8Hz, 1H), 7.47 (d, J = 7.9Hz, 1H), 7.24 ( d,J=2.5Hz,2H),7.01(d,J=9.4Hz,2H),6.82(dd,J=9.4,2.6Hz,2H),3.34(s,3H),1.89(s,3H),1.77(s,3H).
[0338] Comparative Example 3
[0339] Synthesis of comparative molecule 3: synthesized according to the literature Nat Biotechnol 37, 1287-1293 (2019), with a yield of 90%. 1H-NMR (400MHz, DMSO-d6): δ = 8.45 (s, 1H), 7.92 (d, J = 8.6Hz, 2H), 7.85 (d, J = 8.3Hz, 3H), 7.73 (dd, J = 8.6, 3.9Hz, 1H), 7.21 ( d,J=1.9Hz,1H),7.11(d,J=1.9Hz,1H),6.96(dd,J=9.1,2.3Hz,1H),3.63-3.57(m,2H),3.52(t,J=5.7Hz,2H),3.05(s,3H).
[0340] Comparative Example 4
[0341] Synthesis of comparative molecule 4: Synthesized with reference to the literature Bioconjugate Chem. 2018, 29, 215-224, with a yield of 96%. 1 H NMR (400MHz, DMSO-d6): δ7.85(s,1H),7.48(s,2H),3.31(t,J=5.5Hz,4H),2.65(t,J=5.9Hz,4H),1.90–1.79(m,4H),1.5(s,9H).
[0342] Test Example 1
[0343] The fluorescent dyes (molecular rotors) prepared in Examples 1-48 were dissolved in dimethyl sulfoxide to prepare a concentration of 1×10 -2 M mother liquor, add each mother liquor into methanol and glycerol respectively, mix well, and prepare the final concentration of 1×10 -5 Fluorescence emission spectra of various solutions of the present invention were measured under the same conditions using the maximum excitation wavelength of each fluorescent dye, as shown in Table 1. These results demonstrate that the fluorescent dyes of the present invention have long excitation and emission wavelengths. In the near-infrared region, the fluorescent dyes can achieve red excitation and red emission, making them suitable for in vivo fluorescence imaging. Furthermore, the fluorescent dyes of the present invention exhibit a high fluorescence intensity ratio in glycerol and methanol, demonstrating their sensitive response to changes in viscosity.
[0344] Table 1 Excitation and emission wavelengths of each molecular rotor in methanol and the ratio of fluorescence intensity in glycerol and methanol solutions
[0345] Test Example 2
[0346] Molecular rotors 2, 9, 12, 19, and 40 were added to methanol and glycerol, respectively, to prepare a final concentration of 1×10 -5 The solution of M, according to the optimum excitation wavelength respectively, is tested the fluorescence spectrum in glycerol and methanol respectively, and with the absorption value under the excitation wavelength tested by ultraviolet spectrometer, obtains their respective fluorescence quantum yield in methanol and glycerol by the calculation method of relative fluorescence quantum yield.In addition, with ultraviolet spectrometer test their respective maximum absorption value in methanol, calculate their respective molar extinction coefficient by Beer-Lambert law.Experimental data is summarized as table 2, and result shows that fluorescent dye of the present invention has higher molar extinction coefficient, and the fluorescence quantum yield of (methanol) is lower under free state, has higher fluorescence quantum yield under the environment that viscosity such as glycerol is higher.
[0347] Table 2 Photophysical properties of representative molecules of molecular rotors in methanol and glycerol
[0348] Test Example 3
[0349] Molecular rotors 2, 9, 12, 19, and 40 were added to the ethylene glycol-glycerol mixed solution to prepare a final concentration of 1×10 -5 The fluorescence emission spectra of the solutions of M under different viscosity conditions are shown in Figures 1, 3, 5, 7, and 9. The fluorescence intensity of the molecular rotors at the same concentration gradually increases under different viscosity conditions, indicating that the fluorescence intensity of the molecular rotors increases with the increase of the environmental viscosity. The relationship between the logarithm of the fluorescence intensity and the logarithm of the solvent viscosity conforms to the Huffman equation and has a good linear relationship, as shown in Figures 2, 4, 6, 8, and 10. This proves that the molecular rotors are sensitive to viscosity and can be used for viscosity testing of unknown samples.
[0350] Test Example 4
[0351] We used the fluorescence decay method to test the photostability of molecular rotors 6, 12, 20, 40, and 42, as well as reference molecules 1 and 2. We placed each sample on a confocal microscope, continuously illuminated the sample with a laser at the corresponding excitation wavelength, and recorded the changes in fluorescence intensity. The test results, shown in Figure 11, show that the fluorescence intensity of the molecular rotors of the present invention decreases slightly with prolonged illumination, while the fluorescence intensity of reference molecules 1 and 2, which are considered to have good photostability, decreases significantly. This demonstrates that the molecular rotors of the present invention possess excellent photostability, making them suitable for long-term dynamic tracking and fluorescence imaging of biological materials.
[0352] Test Example 5
[0353] Molecular rotors 6, 12, 19, 20, 41, and reference molecules 3 and 4 were added to the ethylene glycol-glycerol mixed solution to prepare a final concentration of 1×10 -5Solutions of molecular rotors M were excited at their respective optimal excitation wavelengths, and their fluorescence lifetimes were measured under different viscosity conditions. The experimental results obtained for molecular rotors 6, 12, 19, 20, and 41 are shown in Figures 12, 13, 14, 15, and 16. For molecular rotors of the same concentration, the fluorescence lifetime gradually increases with increasing viscosity of the microenvironment. This demonstrates that changes in fluorescence lifetime can reflect information about the microenvironment, thereby enabling fluorescence lifetime imaging of biomolecules. Furthermore, the molecular rotors of the present invention have a longer fluorescence lifetime, enabling accurate test results even in solutions with lower viscosities (such as ethylene glycol). In contrast, the conventional molecular rotor (comparison molecule 3) has a shorter fluorescence lifetime, only approximately 0.1 ns in solutions as high as glycerol (Figure 17). This makes accurate detection difficult in low-viscosity systems and unsuitable for fluorescence lifetime imaging of biological materials. Furthermore, although the fluorescence lifetime of comparison molecule 4 reaches the detectable range (Figure 18), its changes in viscosity are not significant, making it unsuitable for fluorescence lifetime imaging of biological materials. The above shows that the molecular rotor fluorescent dye of the present invention has a long fluorescence lifetime and changes significantly with viscosity, and is more suitable for fluorescence lifetime imaging of biological substances.
[0354] Test Example 6
[0355] Molecular rotors 6, 12, 20, 40, 42, and control molecules 1 and 2 were added to the cell culture medium to a final concentration of 1 × 10 -6 M solution was prepared and used to culture HeLa cells. After incubation for 2 hours, the cells were excited at the maximum excitation wavelength of each compound, and their fluorescence intensities were detected. The maximum fluorescence of all groups was set as 100 for each sample, as shown in Figure 19. The results show that the molecular rotor of the present invention has lower background fluorescence than dyes with similar structures (comparative molecules 1 and 2).
[0356] Test Example 7
[0357] Molecular rotors 34, 35, 39, and 40 can specifically localize to subcellular organelles (lysosomes, mitochondria, cell membranes, and endoplasmic reticulum, etc.), enabling specific fluorescence imaging of these organelles, as shown in Figure 20. The dyes emit bright fluorescence only at the locations of the subcellular organelles, while nonspecific fluorescence from other locations in the cell and background fluorescence in the culture medium are very weak. This demonstrates that the dyes of the present invention have excellent cell membrane permeability and, after targeting subcellular organelles, can be activated by their microenvironment for fluorescence, making them suitable for specific fluorescence imaging of subcellular organelles.
[0358] Test Example 8
[0359] Molecular rotors 22, 41, and 42 can specifically bind to protein tags Halo-Tag and SNAP-Tag. Before binding, the dyes basically do not fluoresce, but after binding, the fluorescence is significantly activated. As shown in FIG21 , cells expressing the tagged protein emit bright fluorescence, while cells not expressing the protein do not fluoresce. This indicates that the dyes of the present invention can be used to label proteins in living cells.
[0360] Test Example 9
[0361] Molecular rotors 5, 6, 12, and 19 can be used to screen nucleic acid aptamers, and the screened RNA aptamers can specifically bind. The dye background before binding is very low, and the fluorescence is significantly activated after binding. As shown in Figure 22, the dye can also bind to the RNA aptamer in living cells to emit bright fluorescence, with essentially no nonspecific fluorescence activation. This shows that the dye of the present invention has very low background fluorescence and very low nonspecific fluorescence in cells, and can be used to label low-abundance biomacromolecules such as nucleic acids. The sequence of one of the RNA aptamers is:
[0362] Test Example 10
[0363] Molecular rotors 35, 36, and 39 can achieve in vivo fluorescence imaging of tumors. Subcutaneous sarcomas were implanted in the legs of mice, and the dye was injected intravenously. The experimental results are shown in FIG23 . The tumor site in the mouse leg exhibited a clear fluorescence signal, indicating that the fluorescent dye of the present invention can be specifically enriched at the tumor site and exhibit a strong fluorescence signal, and can be used for in vivo fluorescence imaging of tumors.
Claims
1. A fluorescent dye having a structure as shown in formula (I), in: A is -N(X 1 )(X 2 ) or HO-, B is =N + (X 3 )(X 4 ) or =O, or X 1 ,X 2 With R 2 and / or R 3 , or X 3 ,X 4 With R 4 and / or R 5 Connected to form a heterocyclic group; X 1 , X 2 , X 3 , X 4 Each is independently selected from at least one of hydrogen, alkyl, modified alkyl, aryl, heteroaryl, unsaturated or saturated heterocyclic group, or X 1 With X 2 , or X 3 With X 4 Optionally connected to each other are saturated or unsaturated unsubstituted or R 1-1 Substituted heterocyclic or heteroaromatic ring, or X 1 ,X 2 With R 2 and / or R 3 , or X 3 ,X 4 With R 4 and / or R 5 Optionally connected to each other are saturated or unsaturated unsubstituted or R 1-1 substituted heterocyclic group; and / or R 1 ,R 2 ,R 3 ,R 4 ,R 5 ,R 6 Optionally independently selected from hydrogen, a halogen atom, a nitro group, or an alkyl group; When K is selected from S, Se, Te, Te=O, unsubstituted or 1 or 2 R 1-1 Substituted carbon, unsubstituted or 1 or 2 R 1-1 Substituted germanium, (R 0 Each independently selected ), G is selected from the following formula (I-1-1), formula (I-1-2), formula (I-1-3) or formula (I-1-4); When K is selected from O or unsubstituted or 1 or 2 R 1-1 substituted silicon, and A is not -N(X 1 )(X 2 ), G is selected from the following formula (I-1-1), formula (I-1-2), formula (I-1-3) or formula (I-1-4). When K is selected from O or unsubstituted or 1 or 2 R 1-1 Substituted silicon, A is -N(X 1 )(X 2 ) and B is =N+(X 3 )(X 4 ), G is selected from the following formula (I-1-2) or formula (I-1-3); in, Each R 1-1 Each is independently selected from a halogen atom or an alkyl group; Each Y is independently selected from O, S, NH, Se, or Te; Each Z is independently selected from C, or N, Each R a , each R b , each R c Each is independently selected from hydrogen, sulfonic acid group, haloacyl group, cyano group, cyanate group, isothiocyanate group, carboxyl group, ester group, amide group, nitro group, halogen atom, alkyl group, haloalkyl group, modified alkyl group; The C ring in formula (I-1-2) and the E ring in formula (I-1-3) are each independently selected from at least one of an aromatic ring or an aromatic heterocyclic ring; Each hydrogen atom in formula (I-1-2) and formula (I-1-3) is optionally independently substituted by a halogen atom or an alkyl group; D in formula (I-1-2) and F in formula (I-1-3) are each independently selected from hydrogen, cyano, amino, isothiocyanate, carboxyl, sulfone, phosphite, ester, amide, nitro, halogen, alkyl, aryl, heteroaryl, or modified alkyl; in, The "alkyl" is C 1 -C 10 Straight or branched chain alkyl; preferably, C 1 -C 7 Straight or branched chain alkyl; preferably, C 1 -C 5 Straight-chain or branched alkyl; preferably, selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, isopentyl, 1-ethylpropyl, neopentyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, isohexyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, 2-ethylbutyl, n-heptyl, 2-methylhexyl, 3-methylhexyl, 2,2-dimethylpentyl, 3,3-dimethylpentyl, 2,3-dimethylpentyl, 2,4-dimethylpentyl, 3-ethylpentyl or 2,2,3-trimethylbutyl; The "modified alkyl" is an alkyl group in which any carbon atom is selected from halogen atoms, -O-, -OH, -CO-, -NO 2 、-CN、-S-、-SO 2 -, -(S=O)-, a group obtained by replacing at least one group of an aryl group, an amino group, a secondary amino group, a tertiary amino group, a heterocyclic group, a saturated or unsaturated monocyclic or heterocyclic group optionally substituted by a halogen atom, wherein the modified alkyl group has 1 to 30 carbon atoms (preferably 1 to 20 carbon atoms, more preferably within 10 carbon atoms), and its carbon-carbon single bond is optionally independently replaced by a carbon-carbon double bond or a carbon-carbon triple bond; The carbon atom is replaced, which means that the carbon atom or the carbon atom together with the hydrogen atoms thereon are replaced by the corresponding group; The "heterocyclic group" is a 4-10 membered monocyclic or polycyclic heterocyclic group containing at least one heteroatom selected from N, O, S or Si in the ring; The "aryl" or "aromatic ring" is a 5-10 membered monocyclic or fused bicyclic aromatic group; The "heteroaryl" or "aromatic heterocycle" is a 5-10 membered monocyclic or fused bicyclic heteroaromatic group containing at least one heteroatom selected from N, O, S or Si in the ring; The halogen atoms in the "halogen atom", "haloalkyl", "haloacyl" and "aryl substituted with halogen atom" are each independently selected from F, Cl, Br and I; The "ester group" is -(C=O)OR 1-2 Group; The "amide group" is -CONR 1-2 Group; The "sulfone group" is -SO 2 R 1-2 Group; The "sulfoxide"-SOR 1-2 Group; The "secondary amino group" is -NHR 1-2 Group; The "tertiary amino group" is -NR 1-2 R 1-3 Group; Each R 1-2 , R 1-3 Each is independently H, an alkyl group, a modified alkyl group or a halogen atom.
2. The fluorescent dye according to claim 1, It is characterized in that X 1 ,X 2 With R 2 and / or R 3 The saturated or unsaturated heterocyclic groups optionally connected to each other are selected from any group of the following formulae: X 3 ,X 4 With R 4 and / or R 5 The saturated or unsaturated heterocyclic groups optionally connected to each other are selected from any group of the following formulae: Preferably, X 1 ,X 2 With R 2 and / or R 3 or X 3 ,X 4 With R 4 and / or R 5 The heterocyclic group is a symmetrical structure. structure; Preferably, each R' is independently selected from hydrogen or alkyl; Preferably, X 1 With X 2 The saturated or unsaturated heterocyclic groups optionally connected to each other are selected from any group of the following formulae, which are optionally substituted by halogen atoms; Preferably, X 3 With X 4 The saturated or unsaturated heterocyclic groups optionally connected to each other are selected from any group of the following formulae, which are optionally substituted by halogen atoms; Preferably, X 1 With X 2、 X 3 With X 4 The composed heterocyclic group is a symmetrical structure; Preferably, K is selected from oxygen, sulfur, selenium, tellurium or the following groups: Preferably, formula (I-1-1) and (I-1-4) are selected from any of the following groups: Preferably, formula (I-1-2) can be selected from any of the following groups: Alternatively, formula (I-1-3) may be selected from any of the following groups:
3. The fluorescent dye according to claim 1 or 2, It is characterized in that The fluorescent dye is selected from the following compounds:
4. A method for preparing the fluorescent dye according to any one of claims 1 to 3, It is characterized in that The method comprises reacting a brominated aromatic ring compound represented by formula (II-1-1), formula (II-1-2), formula (II-1-3) or formula (II-1-4) with a ketone represented by (II-2) to obtain a fluorescent dye represented by formula (I):
5. A fluorescence-activated biomaterial-specific labeling method, It is characterized in that The method comprises the following steps: after the fluorescent dye described in any one of claims 1 to 3 is brought into contact with a biological substance (including protein, RNA or DNA), the fluorescent dye and the biological substance are covalently or non-covalently bound to each other, thereby specifically activating the fluorescence of the dye molecule and achieving specific fluorescent labeling of the biological substance; Optionally, the reaction medium of the labeling reaction is selected from a pure analyte solution (pure protein, pure DNA and RNA), a cell lysate or an in situ medium where the analyte is located; optionally, the in situ medium is an intracellular medium, an intracellular organelle medium, a living tissue medium, blood or a body fluid.
6. A probe kit, It is characterized in that A fluorescent dye comprising any one of claims 1 to 3; Optionally, the probe kit further comprises a biocompatible medium; optionally, the biocompatible medium is selected from at least one of dimethyl sulfoxide, a buffer, and physiological saline; optionally, the buffer comprises a phosphate buffer.
7. A pharmaceutical preparation, It is characterized in that A fluorescent dye comprising any one of claims 1 to 3; Optionally, the pharmaceutical preparation is a pharmaceutical composition prepared by mixing the fluorescent dye according to any one of claims 1 to 3 with other compounds and suitable for administration to animals or humans, and the pharmaceutical composition also includes a physiologically acceptable carrier for animals or humans. Optionally, the physiologically acceptable carrier includes water, saline, and may also include pharmaceutical agents such as buffers, and other pharmaceutical agents such as compatible preservatives used in pharmaceutical dosage forms; preferably the carrier It is a liquid, more preferably an aqueous solution.
8. Use of the fluorescent dye according to any one of claims 1 to 3 in the preparation of a pharmaceutical preparation for in vitro disease detection.
9. The use according to claim 8, It is characterized in that The in vitro disease detection includes labeling fluorescent dye molecules on antibodies to detect diseases through antigen-antibody interaction; or using dye molecules as targets to screen nucleic acid aptamers, and using the screened aptamers to perform fluorescent imaging of target nucleic acids and as probes for the detection of various disease markers.
10. Use of the fluorescent dye according to any one of claims 1 to 3 in the preparation of an optical imaging system for in vivo fluorescence imaging detection or treatment; Optionally, the in vivo fluorescence imaging detection or treatment includes performing fluorescence-guided surgery or in vitro tissue staining on humans or animals by fluorescence imaging or fluorescence lifetime imaging; Optionally, the optical imaging system includes an imager or various optical fibers, laparoscopy, or endoscopes used in conjunction with fluorescence imaging of humans or animals.
Citation Information
Patent Citations
Heterocycle-substituted xanthene dyes
CN102712614A
Xanthene-based pigment, coloring composition containing the pigment, coloring agent for color filter and color filter
CN111378295A
Combinatorial rosamine library to detect cell-state switching
US20090227467A1
Fluorescent DYES, fluorescent dye kits, and methods of preparing labeled molecules
WO2012129128A1
